Encompass Health Corporation(NYSE:EHC) 
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatmen...
Website: http://www.encompasshealth.com
Founded: 1984
Full Time Employees: 27,970
Sector: Healthcare
Industry: Medical Care Facilities
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2011-03-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2010-01-20 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net operating revenues | 1,586,600,000 | 1,544,600,000 | 1,477,500,000 | 1,457,700,000 | 1,455,400,000 | 1,405,000,000 | 1,351,000,000 | 1,301,200,000 | 1,316,000,000 | 1,246,800,000 | 1,206,900,000 | 1,187,100,000 | 1,160,400,000 | 1,137,300,000 | 1,089,500,000 | 1,330,500,000 | 1,333,600,000 | 1,318,700,000 | 1,284,800,000 | 1,287,700,000 | 1,230,400,000 | 1,214,400,000 | 1,173,900,000 | 1,074,100,000 | 1,182,000,000 | 1,184,400,000 | 1,161,600,000 | 1,135,000,000 | 1,124,000,000 | 1,096,000,000 | 1,067,600,000 | 1,067,700,000 | 1,046,000,000 | 1,019,700,000 | 995,600,000 | 981,300,000 | 974,800,000 | 949,900,000 | 926,800,000 | 920,700,000 | 909,800,000 | 879,300,000 | 778,600,000 | 764,400,000 | 740,600,000 | 596,900,000 | 604,400,000 | 591,200,000 | 572,100,000 | 564,000,000 | 564,500,000 | 572,600,000 | 552,900,000 | 537,000,000 | 538,100,000 | 490,700,000 | 496,900,000 | 491,000,000 | 479,600,000 | 472,700,000 | 483,700,000 | 475,100,000 | 456,200,000 | 461,400,000 | 469,000,000 | 439,000,000 | 431,600,000 | 442,800,000 | 448,600,000 | 731,207,000 | 787,513,000 | 791,987,000 |
operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
salaries and benefits | 818,100,000 | 801,100,000 | 784,800,000 | 767,700,000 | 762,300,000 | 756,800,000 | 732,100,000 | 700,500,000 | 711,600,000 | 676,300,000 | 658,600,000 | 636,200,000 | 629,000,000 | 614,400,000 | 605,600,000 | 773,800,000 | 776,000,000 | 761,000,000 | 730,100,000 | 708,200,000 | 687,200,000 | 686,100,000 | 664,900,000 | 651,900,000 | 679,100,000 | 668,500,000 | 660,800,000 | 622,900,000 | 620,800,000 | 613,300,000 | 592,300,000 | 578,200,000 | 570,200,000 | 554,600,000 | 542,100,000 | 527,800,000 | 530,100,000 | 516,300,000 | 497,400,000 | 486,100,000 | 486,100,000 | 466,800,000 | 417,100,000 | 401,800,000 | 385,100,000 | 290,000,000 | 285,300,000 | 286,100,000 | 272,000,000 | 269,500,000 | 273,600,000 | 274,600,000 | 269,500,000 | 262,300,000 | 259,100,000 | 246,400,000 | 241,600,000 | 241,900,000 | 239,600,000 | 235,400,000 | 239,100,000 | 234,700,000 | 236,500,000 | 236,700,000 | 232,900,000 | 227,000,000 | 213,100,000 | 217,200,000 | 217,400,000 | 344,385,000 | 354,870,000 | 363,860,000 |
other operating expenses | 241,900,000 | 226,300,000 | 231,100,000 | 213,800,000 | 217,500,000 | 206,400,000 | 202,400,000 | 189,900,000 | 203,900,000 | 184,800,000 | 183,700,000 | 172,700,000 | 177,900,000 | 170,100,000 | 172,000,000 | 193,400,000 | 182,100,000 | 176,800,000 | 173,400,000 | 172,700,000 | 162,300,000 | 163,100,000 | 163,400,000 | 148,300,000 | 159,600,000 | 167,100,000 | 156,600,000 | 149,800,000 | 150,100,000 | 151,600,000 | 142,900,000 | 149,400,000 | 141,200,000 | 139,500,000 | 137,600,000 | 130,500,000 | 129,100,000 | 125,100,000 | 126,300,000 | 121,500,000 | 119,200,000 | 118,000,000 | 106,700,000 | 104,200,000 | 103,200,000 | 89,400,000 | 86,300,000 | 84,500,000 | 81,700,000 | 82,200,000 | 81,000,000 | 78,100,000 | 81,000,000 | 75,400,000 | 76,700,000 | 71,200,000 | 76,600,000 | 66,900,000 | 69,800,000 | 66,800,000 | 67,600,000 | 67,200,000 | 68,900,000 | 65,100,000 | 70,400,000 | 48,200,000 | 66,100,000 | 60,700,000 | 70,300,000 | 147,052,000 | 168,442,000 | 154,182,000 |
occupancy costs | 15,200,000 | 14,500,000 | 14,900,000 | 14,700,000 | 14,900,000 | 14,700,000 | 14,400,000 | 14,200,000 | 14,000,000 | 14,000,000 | 14,200,000 | 14,300,000 | 13,800,000 | 13,100,000 | 12,400,000 | 19,300,000 | 20,900,000 | 20,000,000 | 19,800,000 | 20,200,000 | 20,200,000 | 20,400,000 | 20,300,000 | 20,300,000 | 20,200,000 | 20,600,000 | 21,800,000 | 20,300,000 | 19,600,000 | 20,300,000 | 19,600,000 | 19,500,000 | 18,600,000 | 18,700,000 | 18,600,000 | 18,300,000 | 17,900,000 | 17,800,000 | 17,600,000 | 17,900,000 | 18,000,000 | 16,800,000 | 12,500,000 | 12,500,000 | 12,100,000 | 10,300,000 | 10,300,000 | 10,500,000 | 11,200,000 | 11,700,000 | 11,900,000 | 12,200,000 | 12,000,000 | 11,800,000 | 12,300,000 | 12,100,000 | 11,400,000 | 11,600,000 | 11,700,000 | 11,800,000 | 12,100,000 | 12,000,000 | 12,800,000 | 12,500,000 | 12,300,000 | 13,900,000 | 12,800,000 | 13,300,000 | 13,300,000 | |||
supplies | 64,300,000 | 64,500,000 | 64,600,000 | 63,100,000 | 62,200,000 | 62,300,000 | 60,600,000 | 57,600,000 | 58,500,000 | 58,600,000 | 53,900,000 | 52,000,000 | 53,800,000 | 53,900,000 | 51,100,000 | 52,800,000 | 56,100,000 | 54,200,000 | 53,200,000 | 50,000,000 | 51,900,000 | 51,700,000 | 52,500,000 | 50,600,000 | 45,700,000 | 43,200,000 | 42,900,000 | 41,700,000 | 40,100,000 | 40,900,000 | 38,600,000 | 39,300,000 | 39,900,000 | 38,700,000 | 36,500,000 | 37,100,000 | 37,000,000 | 35,800,000 | 34,800,000 | 34,400,000 | 35,000,000 | 34,600,000 | 31,000,000 | 31,700,000 | 31,400,000 | 26,600,000 | 27,800,000 | 27,600,000 | 27,100,000 | 25,500,000 | 26,600,000 | 26,200,000 | 26,200,000 | 23,800,000 | 29,900,000 | 27,800,000 | 28,800,000 | 28,300,000 | 28,500,000 | 27,700,000 | 28,700,000 | 27,500,000 | 26,200,000 | 28,000,000 | 27,500,000 | 25,600,000 | 24,200,000 | 25,800,000 | 26,300,000 | 69,584,000 | 73,631,000 | 76,107,000 |
general and administrative expenses | 58,200,000 | 68,400,000 | 56,100,000 | 59,400,000 | 52,300,000 | 54,500,000 | 54,000,000 | 50,500,000 | 50,200,000 | 53,100,000 | 49,800,000 | 55,400,000 | 43,400,000 | 42,800,000 | 37,900,000 | 60,300,000 | 48,400,000 | 60,600,000 | 43,900,000 | 54,200,000 | 38,600,000 | 37,800,000 | 39,100,000 | 43,000,000 | 35,600,000 | 64,000,000 | 52,500,000 | 77,100,000 | 53,400,000 | 54,300,000 | 49,900,000 | 54,900,000 | 61,100,000 | 43,100,000 | 39,700,000 | 52,400,000 | 36,500,000 | 36,800,000 | 30,300,000 | 34,400,000 | 31,900,000 | 36,000,000 | 30,600,000 | 32,100,000 | 34,600,000 | 27,500,000 | 30,200,000 | 30,700,000 | 30,600,000 | 28,800,000 | 29,500,000 | 30,200,000 | 30,600,000 | 29,300,000 | 26,900,000 | 24,900,000 | 26,700,000 | 26,300,000 | 28,100,000 | 26,000,000 | 24,900,000 | 25,500,000 | 25,500,000 | 25,200,000 | 28,100,000 | 27,600,000 | 27,500,000 | 35,000,000 | 44,700,000 | |||
depreciation and amortization | 87,300,000 | 86,400,000 | 82,400,000 | 79,900,000 | 79,200,000 | 78,000,000 | 78,400,000 | 72,900,000 | 70,300,000 | 70,100,000 | 67,300,000 | 72,600,000 | 63,900,000 | 63,300,000 | 62,100,000 | 68,800,000 | 66,200,000 | 65,800,000 | 64,900,000 | 63,400,000 | 62,500,000 | 62,300,000 | 61,200,000 | 60,700,000 | 58,800,000 | 58,400,000 | 55,100,000 | 52,700,000 | 52,500,000 | 52,900,000 | 51,200,000 | 49,700,000 | 45,900,000 | 46,600,000 | 46,200,000 | 45,800,000 | 45,200,000 | 43,800,000 | 43,500,000 | 42,900,000 | 42,400,000 | 41,400,000 | 33,700,000 | 32,700,000 | 31,900,000 | 27,400,000 | 26,400,000 | 26,400,000 | 25,200,000 | 24,300,000 | 23,100,000 | 22,100,000 | 21,700,000 | 21,300,000 | 20,300,000 | 19,300,000 | 18,700,000 | 18,300,000 | 17,500,000 | 18,100,000 | 17,700,000 | 17,600,000 | 18,100,000 | 18,300,000 | 30,100,000 | 19,700,000 | 19,900,000 | 20,000,000 | 18,200,000 | 38,473,000 | 38,917,000 | 37,109,000 |
total operating expenses | 1,285,000,000 | 1,261,200,000 | 1,233,900,000 | 1,198,600,000 | 1,188,400,000 | 1,172,700,000 | 1,141,900,000 | 1,085,600,000 | 1,108,500,000 | 1,056,900,000 | 1,027,500,000 | 1,003,200,000 | 981,800,000 | 957,600,000 | 941,100,000 | 1,168,400,000 | 1,149,700,000 | 1,138,400,000 | 1,085,300,000 | 1,068,700,000 | 1,022,700,000 | 1,021,400,000 | 1,001,400,000 | 974,800,000 | 1,001,800,000 | 1,021,800,000 | 989,700,000 | 964,500,000 | 936,500,000 | 985,300,000 | 894,500,000 | 891,000,000 | 876,900,000 | 841,200,000 | 820,700,000 | 811,900,000 | 795,800,000 | 775,600,000 | 749,900,000 | 738,900,000 | 732,800,000 | 713,400,000 | 632,000,000 | 615,100,000 | 608,500,000 | 475,200,000 | 467,500,000 | 467,400,000 | 449,300,000 | 424,900,000 | 445,900,000 | 444,800,000 | 440,900,000 | 426,100,000 | 434,600,000 | 412,100,000 | 415,800,000 | 403,100,000 | 398,500,000 | 410,400,000 | 446,500,000 | 382,300,000 | 416,000,000 | 390,600,000 | 376,200,000 | 293,075,000 | 383,400,000 | 389,100,000 | 410,400,000 | 672,037,000 | 737,426,000 | 719,459,000 |
loss on early extinguishment of debt | 200,000 | 200,000 | 400,000 | 1,100,000 | 300,000 | 1,000,000 | 5,400,000 | 2,300,000 | 300,000 | 10,400,000 | 2,600,000 | 2,400,000 | 2,400,000 | 2,400,000 | 18,800,000 | 1,200,000 | 2,700,000 | 1,300,000 | 2,100,000 | 3,400,000 | 300,000 | 4,975,000 | 2,200,000 | 17,700,000 | 4,565,000 | 361,077,000 | ||||||||||||||||||||||||||||||||||||||||||||||
interest expense and amortization of debt discounts and fees | 31,800,000 | 30,200,000 | 30,800,000 | 30,400,000 | 31,800,000 | 33,000,000 | 34,900,000 | 34,300,000 | 35,200,000 | 34,900,000 | 35,900,000 | 36,300,000 | 36,400,000 | 37,500,000 | 38,200,000 | 60,600,000 | 39,600,000 | 40,100,000 | 39,900,000 | 41,800,000 | 42,800,000 | 46,200,000 | 49,000,000 | 45,800,000 | 43,200,000 | 44,500,000 | 40,300,000 | 37,700,000 | 37,200,000 | 36,700,000 | 37,300,000 | 37,700,000 | 35,600,000 | 35,900,000 | 36,800,000 | 40,400,000 | 41,300,000 | 41,600,000 | 42,500,000 | 43,400,000 | 44,600,000 | 44,600,000 | 35,600,000 | 30,900,000 | 31,800,000 | 27,800,000 | 27,800,000 | 27,900,000 | 26,500,000 | 25,300,000 | 24,400,000 | 24,200,000 | 24,300,000 | 23,500,000 | 35,100,000 | 30,800,000 | 30,100,000 | 30,500,000 | 30,800,000 | 29,500,000 | 31,100,000 | 34,400,000 | 47,400,000 | 44,475,000 | 60,200,000 | 59,200,000 | 58,500,000 | 82,493,000 | 82,974,000 | 85,375,000 | ||
other income | -18,700,000 | -3,700,000 | -5,900,000 | -6,700,000 | -2,500,000 | -4,500,000 | -9,300,000 | -3,300,000 | -5,400,000 | -5,900,000 | -400,000 | -4,600,000 | -4,200,000 | -2,500,000 | -5,800,000 | -3,600,000 | -21,000,000 | -2,200,000 | 700,000 | -1,700,000 | -1,300,000 | -1,200,000 | -1,000,000 | -900,000 | -1,000,000 | -800,000 | -800,000 | -700,000 | -600,000 | -1,300,000 | -700,000 | -3,000,000 | -500,000 | -200,000 | -28,200,000 | -1,700,000 | -1,300,000 | -600,000 | -1,900,000 | -700,000 | -1,100,000 | -6,100,000 | -600,000 | -700,000 | -1,400,000 | -700,000 | -2,000,000 | -600,000 | -1,000,000 | 200,000 | -400,000 | -1,000,000 | -700,000 | -1,000,000 | -9,400,000 | -400,000 | -4,800,000 | |||||||||||||||
equity in net income of nonconsolidated affiliates | -400,000 | -800,000 | -1,200,000 | -1,400,000 | -900,000 | -200,000 | -700,000 | -1,400,000 | -700,000 | -900,000 | -1,000,000 | -900,000 | -400,000 | -300,000 | -700,000 | -1,000,000 | -900,000 | -1,100,000 | -900,000 | -1,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -700,000 | -800,000 | -1,200,000 | -1,200,000 | -1,800,000 | -2,500,000 | -2,300,000 | -2,100,000 | -2,000,000 | -2,300,000 | -1,800,000 | -2,100,000 | -2,000,000 | -2,100,000 | -2,500,000 | -2,500,000 | -2,400,000 | -2,400,000 | -2,400,000 | -2,400,000 | -2,300,000 | -1,600,000 | -1,900,000 | -2,600,000 | -4,300,000 | -3,000,000 | -2,000,000 | -3,300,000 | -2,900,000 | -3,000,000 | -3,300,000 | -2,500,000 | -2,300,000 | -2,600,000 | -1,800,000 | -3,000,000 | -2,500,000 | -2,700,000 | -2,700,000 | -2,400,000 | -2,900,000 | -2,300,000 | -2,400,000 | -2,700,000 | -6,677,000 | -5,618,000 | -4,545,000 | ||
income from continuing operations before income tax expense | 288,700,000 | 257,700,000 | 219,900,000 | 236,800,000 | 238,600,000 | 201,400,000 | 183,800,000 | 186,000,000 | 178,400,000 | 164,800,000 | 145,000,000 | 151,200,000 | 146,200,000 | 150,900,000 | 107,300,000 | 95,100,000 | 141,300,000 | 147,200,000 | 160,900,000 | 181,800,000 | 167,300,000 | 149,700,000 | 127,000,000 | 60,000,000 | 135,900,000 | 117,500,000 | 153,800,000 | 134,500,000 | 156,500,000 | 75,600,000 | 139,600,000 | 142,300,000 | 135,700,000 | 135,900,000 | 128,300,000 | 107,800,000 | 124,400,000 | 121,500,000 | 120,300,000 | 123,700,000 | 116,500,000 | 108,600,000 | 103,400,000 | 94,000,000 | 89,600,000 | 94,400,000 | 92,400,000 | 99,800,000 | 81,900,000 | 88,500,000 | 56,100,000 | 57,500,000 | 4,000,000 | -9,200,000 | -25,900,000 | -68,271,000 | -28,941,000 | -404,360,000 | ||||||||||||||
provision for income tax expense | 56,400,000 | 55,400,000 | 44,900,000 | 51,000,000 | 41,600,000 | 37,600,000 | 36,000,000 | 38,300,000 | 38,300,000 | 37,200,000 | 30,300,000 | 32,800,000 | 31,900,000 | 31,900,000 | 21,800,000 | 23,800,000 | 31,200,000 | 31,500,000 | 34,100,000 | 39,500,000 | 34,500,000 | 38,000,000 | 26,900,000 | 11,800,000 | 27,100,000 | 27,300,000 | 34,300,000 | 23,500,000 | 30,800,000 | 29,400,000 | 30,200,000 | 29,300,000 | 30,000,000 | 49,200,000 | 43,100,000 | 28,600,000 | 39,700,000 | 39,700,000 | 42,100,000 | 42,400,000 | 43,500,000 | 35,900,000 | 32,200,000 | |||||||||||||||||||||||||||||
income from continuing operations | 232,300,000 | 202,300,000 | 175,000,000 | 185,800,000 | 197,000,000 | 163,800,000 | 147,800,000 | 147,700,000 | 140,100,000 | 127,600,000 | 114,700,000 | 118,400,000 | 114,300,000 | 119,000,000 | 85,500,000 | 71,300,000 | 110,100,000 | 115,700,000 | 126,800,000 | 142,300,000 | 132,800,000 | 111,700,000 | 100,100,000 | 48,200,000 | 108,800,000 | 90,200,000 | 119,500,000 | 111,000,000 | 125,700,000 | 46,200,000 | 109,400,000 | 113,000,000 | 105,700,000 | 86,700,000 | 85,200,000 | 79,200,000 | 84,700,000 | 81,800,000 | 78,200,000 | 81,300,000 | 76,800,000 | 65,100,000 | 67,500,000 | 61,800,000 | 59,300,000 | 65,700,000 | 94,100,000 | 61,600,000 | 64,100,000 | 73,200,000 | 178,900,000 | 66,300,000 | 57,400,000 | 60,400,000 | 77,100,000 | 42,500,000 | 57,400,000 | 53,600,000 | 38,000,000 | 30,200,000 | 2,200,000 | 56,300,000 | 9,400,000 | 47,200,000 | 3,900,000 | 55,875,000 | 250,000,000 | 1,100,000 | -29,200,000 | -72,853,000 | -38,027,000 | -422,293,000 |
income from discontinued operations, net of tax | 15,900,000 | -8,500,000 | -1,300,000 | -1,200,000 | -1,000,000 | -1,500,000 | -18,500,000 | -300,000 | 100,000 | -100,000 | 200,000 | 200,000 | -75,000 | -100,000 | -100,000 | 700,000 | 300,000 | -1,600,000 | -300,000 | -900,000 | 3,800,000 | -100,000 | 100,000 | -900,000 | 100,000 | -400,000 | 1,900,000 | -500,000 | 14,400,000 | -600,000 | 100,000 | -3,100,000 | 8,900,000 | -5,400,000 | 1,400,000 | -3.1 | -0.04 | -0.01 | -0.03 | |||||||||||||||||||||||||||||||||
net income | 248,200,000 | 203,100,000 | 174,600,000 | 184,900,000 | 1.5 | 1.2 | 1.08 | 1.13 | 1.12 | 0.87 | 0.85 | 0.91 | 0.88 | 0.9 | 0.45 | 0.49 | 0.88 | 0.93 | 1.01 | 1.14 | 1.08 | 0.86 | 0.78 | 0.34 | 0.88 | 445,799,997.04 | 0.99 | 0.93 | 1.04 | 47,700,000 | 109,300,000 | 113,200,000 | 105,200,000 | 86,500,000 | 85,100,000 | 79,400,000 | 84,400,000 | 82,100,000 | 78,100,000 | 81,200,000 | 76,700,000 | 65,800,000 | 67,800,000 | 60,200,000 | 59,000,000 | 64,800,000 | 97,900,000 | 61,500,000 | 64,200,000 | 72,300,000 | 179,000,000 | 65,900,000 | 59,300,000 | 59,900,000 | 91,500,000 | 41,900,000 | 57,500,000 | 50,500,000 | 46,900,000 | 24,800,000 | 3,600,000 | 53,500,000 | 6,600,000 | 44,100,000 | 19,800,000 | -45,800,000 | 287,600,000 | 468,300,000 | -56,600,000 | -76,144,000 | -42,436,000 | -435,138,000 |
yoy | 16546666566.67% | 16924999900.00% | 16166666566.67% | 16362831758.41% | 33.93% | 37.93% | 27.06% | 24.18% | 27.27% | -3.33% | 88.89% | 85.71% | 0.00% | -3.23% | -55.45% | -57.02% | -18.52% | 8.14% | 29.49% | 235.29% | 22.73% | -100.00% | -21.21% | -63.44% | -15.38% | 834.59% | -100.00% | -100.00% | -100.00% | -44.86% | 28.44% | 42.57% | 24.64% | 5.36% | 8.96% | -2.22% | 10.04% | 24.77% | 15.19% | 34.88% | 30.00% | 1.54% | -30.75% | -2.11% | -8.10% | -10.37% | -45.31% | -6.68% | 8.26% | 20.70% | 95.63% | 57.28% | 3.13% | 18.61% | 95.10% | 68.95% | 1497.22% | -5.61% | 610.61% | -43.76% | -81.82% | -216.81% | -97.71% | -90.58% | -134.98% | -39.85% | -777.73% | -207.62% | ||||
qoq | 22.21% | 16.32% | -5.57% | 12326666566.67% | 25.00% | 11.11% | -4.42% | 0.89% | 28.74% | 2.35% | -6.59% | 3.41% | -2.22% | 100.00% | -8.16% | -44.32% | -5.38% | -7.92% | -11.40% | 5.56% | 25.58% | 10.26% | 129.41% | -61.36% | -100.00% | 45030302631.31% | 6.45% | -10.58% | -100.00% | -56.36% | -3.45% | 7.60% | 21.62% | 1.65% | 7.18% | -5.92% | 2.80% | 5.12% | -3.82% | 5.87% | 16.57% | -2.95% | 12.62% | 2.03% | -8.95% | -33.81% | 59.19% | -4.21% | -11.20% | -59.61% | 171.62% | 11.13% | -1.00% | -34.54% | 118.38% | -27.13% | 13.86% | 7.68% | 89.11% | 588.89% | -93.27% | 710.61% | -85.03% | 122.73% | -143.23% | -115.92% | -38.59% | -927.39% | -25.67% | 79.43% | -90.25% | |
less: net income attributable to noncontrolling interests | -53,700,000 | -57,000,000 | -48,100,000 | -42,800,000 | -19,600,000 | -20,700,000 | -21,400,000 | -21,400,000 | -25,900,000 | -19,200,000 | -16,400,000 | -17,600,000 | -16,800,000 | -16,400,000 | -18,600,000 | -18,700,000 | -18,800,000 | -17,100,000 | -17,300,000 | -16,500,000 | -14,700,000 | -14,800,000 | -14,800,000 | -15,300,000 | -14,100,000 | -13,800,000 | -14,600,000 | -12,300,000 | -12,800,000 | -11,700,000 | -10,100,000 | -10,200,000 | -9,800,000 | -8,300,000 | -8,000,000 | -9,100,000 | -8,600,000 | |||||||||||||||||||||||||||||||||||
net income attributable to encompass health | 194,500,000 | 146,100,000 | 126,500,000 | 142,100,000 | 151.5 | 120.9 | 108.2 | 114.1 | 112.5 | 87.6 | 85.3 | 91.4 | 87.7 | 89.4 | 45.4 | 48.7 | 87.5 | 91.6 | 100 | 113.3 | 107.3 | 86 | 77.7 | 33.5 | 87 | 358,699,708.9 | 97.6 | 91.2 | 102.3 | 28,100,000 | 88,600,000 | 91,800,000 | 83,800,000 | |||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 99,200,000 | 100,500,000 | 100,500,000 | 100,600,000 | 100,500,000 | 99,900,000 | 99,900,000 | 99,900,000 | 99,800,000 | 99,500,000 | 99,500,000 | 99,500,000 | 99,400,000 | 99,200,000 | 99,200,000 | 99,200,000 | 99,200,000 | 99,000,000 | 99,000,000 | 99,000,000 | 99,000,000 | 98,600,000 | 98,700,000 | 98,700,000 | 98,200,000 | 98,000,000 | 97,800,000 | 98,000,000 | 98,400,000 | 97,900,000 | 98,000,000 | 97,900,000 | 97,800,000 | 93,700,000 | 97,800,000 | 90,300,000 | 88,800,000 | 89,100,000 | 89,100,000 | 89,300,000 | 89,500,000 | 89,400,000 | 90,600,000 | 89,800,000 | 87,100,000 | 86,500,000 | 86,700,000 | 87,300,000 | 88,100,000 | 86,100,000 | 94,000,000 | 94,600,000 | 94,700,000 | 93,100,000 | 92,800,000 | 92,800,000 | 92,700,000 | 88,800,000 | 87,600,000 | 87,600,000 | 87,500,000 | 79,500,000 | 78,900,000 | 78,700,000 | 78,700,000 | 78,700,000 | 79,631,000 | 398,165,000 | 397,735,000 | |||
diluted | 100,600,000 | 102,200,000 | 102,300,000 | 102,300,000 | 102,100,000 | 102,200,000 | 102,100,000 | 102,000,000 | 102,200,000 | 101,300,000 | 101,400,000 | 101,100,000 | 100,900,000 | 100,400,000 | 100,500,000 | 100,300,000 | 100,200,000 | 100,200,000 | 100,200,000 | 100,200,000 | 100,200,000 | 99,800,000 | 99,900,000 | 99,900,000 | 99,600,000 | 99,400,000 | 99,400,000 | 99,300,000 | 99,700,000 | 99,800,000 | 100,000,000 | 99,600,000 | 99,400,000 | 99,300,000 | 99,000,000 | 98,900,000 | 99,000,000 | 99,500,000 | 99,400,000 | 99,400,000 | 99,400,000 | 101,000,000 | 101,500,000 | 101,500,000 | 101,100,000 | 100,500,000 | 100,600,000 | 100,900,000 | 102,100,000 | 99,800,000 | 107,100,000 | 108,100,000 | 108,100,000 | 109,000,000 | 108,300,000 | 108,200,000 | 108,000,000 | 103,300,000 | 102,200,000 | 101,500,000 | 100,900,000 | 93,000,000 | 92,300,000 | 92,000,000 | 92,100,000 | 92,100,000 | 92,944,000 | 464,511,000 | 414,754,000 | |||
earnings per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic earnings per share attributable to encompass health common shareholders: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations | 1.8 | 1.44 | 1.26 | 1.42 | 1.5 | 1.2 | 1.09 | 1.14 | 1.13 | 0.95 | 0.86 | 0.92 | 0.89 | 0.91 | 0.64 | 0.49 | 0.88 | 0.93 | 1.01 | 1.14 | 1.08 | 0.86 | 0.78 | 0.34 | 0.88 | 0.69 | 0.99 | 0.93 | 1.05 | 0.28 | 0.9 | 0.93 | 0.86 | 0.62 | 0.67 | 0.7 | 0.75 | 0.74 | 0.69 | 0.7 | 0.65 | 0.51 | 0.56 | 0.49 | 0.47 | 0.56 | 0.89 | 0.51 | 1.85 | 0.49 | ||||||||||||||||||||||
discontinued operations | 0.16 | 0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.08 | -0.01 | -0.01 | -0.01 | -0.01 | -0.19 | -0.01 | -0.01 | 0.01 | -0.02 | -0.01 | 0.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share attributable to encompass health common shareholders: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts attributable to encompass health common shareholders: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss from discontinued operations, net of tax | 800,000 | -400,000 | -900,000 | -500,000 | -800,000 | -700,000 | -1,200,000 | -1,300,000 | -100,000 | -100,000 | -150,000 | -500,000 | -100,000 | -100,000 | -500,000 | -200,000 | -100,000 | -300,000 | -100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net and comprehensive income | 196,500,000 | 164,200,000 | 147,100,000 | 146,500,000 | 138,800,000 | 119,100,000 | 113,400,000 | 117,200,000 | 113,300,000 | 117,500,000 | 67,000,000 | 71,300,000 | 110,100,000 | 115,700,000 | 126,700,000 | 142,000,000 | 132,800,000 | 111,700,000 | 100,100,000 | 48,300,000 | 108,700,000 | 88,900,000 | 119,500,000 | 110,900,000 | 125,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||
less: net and comprehensive income attributable to noncontrolling interests | -45,000,000 | -43,300,000 | -38,900,000 | -32,400,000 | -26,300,000 | -31,500,000 | -28,100,000 | -25,800,000 | -25,600,000 | -28,100,000 | -21,600,000 | -22,600,000 | -22,600,000 | -24,100,000 | -26,700,000 | -28,700,000 | -25,500,000 | -25,700,000 | -22,400,000 | -14,800,000 | -21,700,000 | -16,125,000 | -21,900,000 | -19,700,000 | -22,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net and comprehensive income attributable to encompass health | 151,500,000 | 120,900,000 | 108,200,000 | 114,100,000 | 112,500,000 | 87,600,000 | 85,300,000 | 91,400,000 | 87,700,000 | 89,400,000 | 45,400,000 | 48,700,000 | 87,500,000 | 91,600,000 | 100,000,000 | 113,300,000 | 107,300,000 | 86,000,000 | 77,700,000 | 33,500,000 | 87,000,000 | 72,775,000 | 97,600,000 | 91,200,000 | 102,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||
other expense | -8,900,000 | -500,000 | -2,700,000 | -3,600,000 | -8,400,000 | 3,600,000 | 6,300,000 | 3,600,000 | -1,400,000 | 1,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income attributable to noncontrolling interests included in continuing operations | -31,500,000 | -28,100,000 | -25,800,000 | -25,600,000 | -28,100,000 | -21,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income attributable to noncontrolling interests included in discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
government, class action, and related settlements | 2,800,000 | -500,000 | 8,000,000 | -800,000 | -200,000 | -21,300,000 | -2,000,000 | -3,500,000 | 800,000 | 17,100,000 | -8,600,000 | -36,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other loss | -3,700,000 | 100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash dividends per common share | 0.193 | 0.27 | 0.25 | 0.25 | 0.25 | 0.25 | 0.24 | 0.24 | 0.24 | 0.24 | 0.23 | 0.23 | 0.23 | 0.23 | 0.21 | 0.21 | 0.21 | 0.18 | 0.18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
less: provision for doubtful accounts | -9,700,000 | -12,600,000 | -13,700,000 | -16,400,000 | -14,500,000 | -14,800,000 | -15,400,000 | -14,000,000 | -10,700,000 | -10,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net operating revenues less provision for doubtful accounts | 1,010,000,000 | 983,000,000 | 967,600,000 | 958,400,000 | 935,400,000 | 912,000,000 | 905,300,000 | 865,300,000 | 767,900,000 | 753,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
professional fees—accounting, tax, and legal | 1,700,000 | 200,000 | 300,000 | 400,000 | 100,000 | 2,200,000 | 4,000,000 | 2,000,000 | 1,600,000 | 1,700,000 | 4,200,000 | 2,200,000 | 1,400,000 | 2,900,000 | 4,100,000 | 3,800,000 | 5,200,000 | 5,700,000 | 2,900,000 | 3,800,000 | 3,500,000 | -3,300,000 | 4,800,000 | 4,000,000 | 5,300,000 | 3,600,000 | 7,300,000 | 9,200,000 | 13,300,000 | 21,800,000 | 23,774,000 | 27,996,000 | 48,637,000 | |||||||||||||||||||||||||||||||||||||||
net income attributable to healthsouth | 48,925,000 | 65,900,000 | 63,000,000 | 66,800,000 | 65,300,000 | 61,700,000 | 62,600,000 | 58,000,000 | 47,000,000 | 50,700,000 | 42,900,000 | 42,500,000 | 50,100,000 | 83,100,000 | 46,700,000 | 48,900,000 | 58,200,000 | 165,200,000 | 51,300,000 | 47,000,000 | 47,100,000 | 79,800,000 | 31,800,000 | 47,300,000 | 40,700,000 | 38,600,000 | 16,800,000 | -5,500,000 | 44,900,000 | |||||||||||||||||||||||||||||||||||||||||||
basic earnings per share attributable to healthsouth common shareholders: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share attributable to healthsouth common shareholders: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts attributable to healthsouth common shareholders: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: convertible perpetual preferred stock dividends | -1,600,000 | -1,600,000 | -1,500,000 | -1,600,000 | -3,800,000 | -5,700,000 | -5,800,000 | -5,700,000 | -5,800,000 | -5,700,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to healthsouth common shareholders | 65,300,000 | 61,700,000 | 62,600,000 | 58,000,000 | 47,000,000 | 50,700,000 | 42,900,000 | 40,900,000 | 48,500,000 | 81,600,000 | 45,100,000 | -26,500,000 | 52,500,000 | 159,400,000 | 45,600,000 | 41,200,000 | 41,400,000 | 73,300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: benefit from doubtful accounts | -16,500,000 | -11,600,000 | -8,200,000 | -9,300,000 | -7,500,000 | -3,600,000 | -8,000,000 | -7,000,000 | -7,400,000 | -4,950,000 | -7,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net operating revenues less benefit from doubtful accounts | 893,300,000 | 729,000,000 | 588,700,000 | 595,100,000 | 583,700,000 | 568,500,000 | 556,000,000 | 557,500,000 | 565,200,000 | 397,300,000 | 530,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from income tax expense | 39,700,000 | 30,300,000 | 32,800,000 | 33,500,000 | 21,025,000 | 28,100,000 | 2,500,000 | 1,200,000 | 100,000 | 3,300,000 | 4,582,000 | 9,086,000 | 17,933,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations before income tax benefit | 87,800,000 | 130,600,000 | 75,150,000 | 108,400,000 | 35,600,000 | 28,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from income tax benefit | 22,100,000 | 36,500,000 | -4,450,000 | 35,200,000 | -700,000 | -2,400,000 | -1,700,000 | -22,500,000 | 700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: repurchase of convertible perpetual preferred stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from income tax (benefit) expense | -86,500,000 | -5,600,000 | -2,200,000 | -300,000 | -34,200,000 | -281,100,000 | -10,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on disposal of assets | 750,000 | 1,600,000 | 200,000 | 100,000 | 400,000 | 500,000 | 700,000 | 1,300,000 | 200,000 | 800,000 | 550,000 | 600,000 | 1,700,000 | 2,973,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted earnings per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations attributable to healthsouth common shareholders | 307,500 | 440,000 | 400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of tax, attributable to healthsouth common shareholders | 7,500 | -30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 5,400,000 | 4,300,000 | 5,900,000 | 6,900,000 | 7,600,000 | 7,900,000 | 9,700,000 | 7,900,000 | 6,700,000 | 6,700,000 | 8,100,000 | 7,800,000 | 5,700,000 | 10,800,000 | 10,600,000 | 34,309,000 | 29,592,000 | 23,058,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on interest rate swaps | 9,000,000 | 4,300,000 | 2,900,000 | 7,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations before income tax (benefit) expense | 71,500,000 | 1,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
attributable to healthsouth common shareholders | 630,000 | -10,000 | 440,000 | 125,000 | 180,000 | -150,000 | 470,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of tax, | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on early extinguishment of debt | 100,000 | 300,000 | -775,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations before | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | 41,800,000 | -13,100,000 | 47,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common shareholders | 25,300,000 | 40,800,000 | 9,175,000 | 10,300,000 | -12,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations attributable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
to healthsouth common shareholders | 280,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on interest rate swaps | -300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in net (income) loss of nonconsolidated affiliates | -2,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations before income tax | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(benefit) expense | 55,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income available to common shareholders | 34,200,000 | 38,400,000 | 37,600,000 | 13,300,000 | -52,300,000 | 281,100,000 | 461,800,000 | -63,100,000 | -82,644,000 | -51,680,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | 0.37 | 0.44 | 0.17 | -0.8 | -1.04 | -0.13 | -1.09 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets | 1,000,000 | 4,000,000 | 600,000 | 400,000 | 14,700,000 | 193,000 | 3,752,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
government, class action, and related settlements expense | -4,600,000 | 8,500,000 | 48,700,000 | -15,900,000 | -23,400,000 | -12,200,000 | 28,420,000 | 17,186,000 | 128,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders | 0.105 | 0.12 | -0.14 | 100,000 | 0.47 | -70,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts attributable to healthsouth: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on early extinguishment of debt | -1,300,000 | -1,800,000 | -6,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on interest rate swaps | 3,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in net income (income) of nonconsolidated affiliates | 2,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on disposal of assets | 1,000,000 | -400,000 | 2,954,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on interest rate swap | 5,000,000 | 8,000,000 | 36,600,000 | 23,600,000 | 21,400,000 | 4,300,000 | 28,711,000 | 3,815,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of income tax benefit | -2,800,000 | 15,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations, net of tax | 48 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest expense and amortization of debt discounts | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and fees | 40,400,000 | 43,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interests in earnings of consolidated affiliates | 5,900,000 | 8,200,000 | 7,600,000 | 8,200,000 | 7,200,000 | 7,800,000 | 8,800,000 | 21,124,000 | 21,077,000 | 36,123,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible perpetual preferred stock dividends | -6,500,000 | -6,500,000 | -6,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income available to common | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive income: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income, net of tax: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
foreign currency translation adjustment | 800,000 | 25,000 | 100,000 | 439,000 | 288,000 | -411,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
securities | -600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income | 2,026,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
of tax | -600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive income | 6,000,000 | 44,500,000 | 19,400,000 | 174,075,000 | 287,900,000 | 468,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on interest rate swap | -28,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
of income tax benefit | -3,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities | -400,000 | -750,000 | 300,000 | 300,000 | 1,587,000 | -293,000 | 59,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income, net of tax | 400,000 | -725,000 | 300,000 | 300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
to common shareholders | 510,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net of income tax benefit | -40,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive loss, net of tax: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized loss on available-for-sale securities | -400,000 | -3,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive loss, net of tax | -400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations available to common shareholders | -30,000 | -450,000 | -1 | -0.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of income tax | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit | 200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
recovery of amounts due from richard m. scrushy | -35,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
expense | -7,925,000 | 3,900,000 | 467,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax (benefit) expense | -16,175,000 | -31,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax (benefit) expense | -599,300,000 | 37,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible perpetual preferred dividends | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | -9,244,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on interest rate swap | -19,000,000 | -18,604,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations available to common | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax expense | 5,940,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of income tax expense | -27,400,000 | -3,291,000 | -4,409,000 | -12,845,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive loss: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive loss | -3,400,000 | -5,000 | -352,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive loss | -60,000,000 | -74,118,000 | -42,441,000 | -435,490,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted loss per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
professional and medical director fees | 17,867,000 | 19,978,000 | 21,437,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
recovery of amounts due from meadowbrook | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of intangible assets | 7,000 | 108,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest income | -1,253,000 | -4,317,000 | -4,063,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of investments | 3,049,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted loss per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on sale of investments | -1,049,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on disposal of assets | -5,059,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of investments | -894,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2011-03-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-09-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 110,500,000 | 72,200,000 | 48,700,000 | 99,100,000 | 95,800,000 | 85,400,000 | 147,800,000 | 154,400,000 | 134,400,000 | 69,100,000 | 99,700,000 | 117,500,000 | 85,000,000 | 21,800,000 | 59,800,000 | 186,500,000 | 94,200,000 | 54,800,000 | 94,800,000 | 73,200,000 | 223,900,000 | 224,000,000 | 450,000,000 | 419,000,000 | 104,900,000 | 94,800,000 | 422,000,000 | 221,700,000 | 56,100,000 | 69,200,000 | 56,900,000 | 59,000,000 | 86,400,000 | 54,400,000 | 67,600,000 | 71,100,000 | 61,200,000 | 40,500,000 | 76,400,000 | 70,300,000 | 73,200,000 | 61,600,000 | 801,600,000 | 45,500,000 | 272,300,000 | 65,800,000 | 53,100,000 | 64,500,000 | 65,000,000 | 68,700,000 | 80,100,000 | 132,800,000 | 163,200,000 | 141,000,000 | 190,500,000 | 172,600,000 | 116,800,000 | 24,900,000 | 67,200,000 | 60,400,000 | 15,900,000 | 21,000,000 | 26,200,000 | 34,167,000 | 53,856,000 |
restricted cash | 52,900,000 | 30,700,000 | 45,000,000 | 38,300,000 | 27,000,000 | 37,700,000 | 51,100,000 | 27,700,000 | 38,300,000 | 35,100,000 | 41,500,000 | 36,500,000 | 34,300,000 | 31,600,000 | 44,300,000 | 70,800,000 | 61,000,000 | 65,100,000 | 75,900,000 | 65,000,000 | 62,200,000 | 65,400,000 | 57,200,000 | 56,400,000 | 56,700,000 | 57,400,000 | 66,800,000 | 56,800,000 | 59,000,000 | 59,000,000 | 62,100,000 | 65,800,000 | 69,400,000 | 62,400,000 | 60,900,000 | 45,900,000 | 52,400,000 | 49,300,000 | 33,700,000 | 49,700,000 | 76,300,000 | 73,400,000 | 46,600,000 | 64,500,000 | |||||||||||||||||||||
accounts receivable | 676,000,000 | 619,200,000 | 610,800,000 | 612,500,000 | 623,400,000 | 598,800,000 | 576,400,000 | 589,700,000 | 619,300,000 | 611,600,000 | 535,900,000 | 532,300,000 | 514,500,000 | 536,800,000 | 500,100,000 | 658,700,000 | 683,500,000 | 680,300,000 | 637,800,000 | 627,500,000 | 633,600,000 | 572,800,000 | 593,300,000 | 553,200,000 | 543,400,000 | 506,100,000 | 516,900,000 | 496,000,000 | 500,600,000 | 467,700,000 | 458,000,000 | 456,600,000 | 463,100,000 | 472,100,000 | 441,600,000 | 426,500,000 | 438,000,000 | 443,800,000 | 419,200,000 | 420,600,000 | 431,900,000 | 410,500,000 | 350,900,000 | 351,800,000 | 261,600,000 | 272,300,000 | 272,700,000 | 261,800,000 | 253,400,000 | 273,700,000 | 266,300,000 | 249,300,000 | 247,500,000 | 234,100,000 | 414,074,000 | 404,699,000 | |||||||||
other current assets | 189,700,000 | 129,900,000 | 165,300,000 | 168,200,000 | 164,700,000 | 122,700,000 | 158,600,000 | 166,300,000 | 137,800,000 | 91,500,000 | 136,600,000 | 137,700,000 | 127,900,000 | 129,600,000 | 116,400,000 | 111,000,000 | 101,300,000 | 93,600,000 | 81,400,000 | 73,900,000 | 73,100,000 | 79,500,000 | 71,700,000 | 70,400,000 | 67,000,000 | 61,000,000 | 90,200,000 | 89,600,000 | 178,200,000 | 195,900,000 | 183,100,000 | 170,400,000 | 168,600,000 | 127,000,000 | 124,600,000 | 126,700,000 | 110,200,000 | 103,900,000 | 120,500,000 | 119,200,000 | 111,600,000 | 113,400,000 | 138,100,000 | 139,500,000 | 74,900,000 | 56,800,000 | 56,200,000 | 54,900,000 | 56,600,000 | 62,200,000 | 98,400,000 | 69,100,000 | 81,100,000 | 139,246,000 | 103,661,000 | ||||||||||
total current assets | 1,029,100,000 | 905,900,000 | 869,800,000 | 918,100,000 | 910,900,000 | 886,900,000 | 933,900,000 | 938,100,000 | 929,800,000 | 841,800,000 | 813,700,000 | 824,000,000 | 761,700,000 | 717,200,000 | 733,800,000 | 1,032,400,000 | 949,700,000 | 921,400,000 | 909,800,000 | 859,300,000 | 1,001,100,000 | 948,600,000 | 1,174,400,000 | 1,101,700,000 | 784,500,000 | 755,800,000 | 1,077,400,000 | 844,900,000 | 682,700,000 | 662,100,000 | 638,000,000 | 671,600,000 | 708,500,000 | 702,200,000 | 687,400,000 | 693,500,000 | 682,300,000 | 654,500,000 | 666,000,000 | 659,500,000 | 632,100,000 | 598,700,000 | 1,463,000,000 | 712,400,000 | 783,000,000 | 580,900,000 | 585,200,000 | 580,400,000 | 575,100,000 | 591,500,000 | 597,300,000 | 636,800,000 | 548,800,000 | 521,400,000 | 514,300,000 | 503,900,000 | 483,400,000 | 642,200,000 | 678,400,000 | 697,500,000 | 668,900,000 | 682,900,000 | 849,200,000 | 718,612,000 | 723,859,000 |
property and equipment | 4,216,500,000 | 4,101,600,000 | 3,925,500,000 | 3,820,300,000 | 3,723,700,000 | 3,643,100,000 | 3,523,700,000 | 3,438,900,000 | 3,370,300,000 | 3,301,000,000 | 3,186,300,000 | 3,062,200,000 | 2,988,300,000 | 2,939,200,000 | 2,807,400,000 | 2,730,100,000 | 2,667,100,000 | 2,601,600,000 | 2,467,900,000 | 2,391,200,000 | 2,280,500,000 | 2,206,600,000 | 2,094,900,000 | 2,041,400,000 | 2,003,300,000 | 1,959,300,000 | 1,874,800,000 | 1,788,100,000 | 1,736,200,000 | 1,634,800,000 | 1,591,000,000 | 1,565,800,000 | 1,554,300,000 | 1,517,100,000 | 1,482,300,000 | 1,452,100,000 | 1,406,100,000 | 1,391,800,000 | 1,353,100,000 | 1,336,900,000 | 1,317,700,000 | 1,310,100,000 | 1,079,100,000 | 1,062,800,000 | 994,600,000 | 976,500,000 | 930,700,000 | 910,500,000 | 893,500,000 | 793,300,000 | 764,200,000 | 748,000,000 | 739,300,000 | 682,500,000 | 683,700,000 | 664,500,000 | 662,000,000 | 676,900,000 | 681,500,000 | 693,900,000 | 755,000,000 | 766,000,000 | 792,300,000 | 1,124,830,000 | 1,153,879,000 |
operating lease right-of-use assets | 205,300,000 | 212,600,000 | 218,100,000 | 215,500,000 | 218,700,000 | 203,700,000 | 209,700,000 | 216,300,000 | 199,100,000 | 208,500,000 | 196,800,000 | 206,200,000 | 212,700,000 | 212,500,000 | 195,700,000 | 238,500,000 | 236,800,000 | 242,000,000 | 239,000,000 | 244,900,000 | 248,300,000 | 245,700,000 | 267,200,000 | 268,500,000 | 267,900,000 | 276,500,000 | 311,400,000 | 284,400,000 | 284,900,000 | ||||||||||||||||||||||||||||||||||||
goodwill | 1,317,600,000 | 1,317,600,000 | 1,303,000,000 | 1,303,000,000 | 1,284,000,000 | 1,284,000,000 | 1,284,000,000 | 1,284,000,000 | 1,281,300,000 | 1,281,300,000 | 1,281,300,000 | 1,270,700,000 | 1,270,700,000 | 1,263,200,000 | 1,247,400,000 | 2,456,500,000 | 2,456,500,000 | 2,427,900,000 | 2,417,600,000 | 2,412,300,000 | 2,318,700,000 | 2,318,700,000 | 2,318,700,000 | 2,318,700,000 | 2,312,100,000 | 2,305,200,000 | 2,305,200,000 | 2,111,600,000 | 2,111,600,000 | 2,100,800,000 | 2,081,100,000 | 2,074,700,000 | 1,973,100,000 | 1,972,600,000 | 1,971,700,000 | 1,949,600,000 | 1,931,400,000 | 1,927,200,000 | 1,915,600,000 | 1,899,700,000 | 1,891,900,000 | 1,890,100,000 | 1,105,000,000 | 1,097,500,000 | 491,700,000 | 491,700,000 | 456,900,000 | 456,900,000 | 457,200,000 | 457,200,000 | 443,400,000 | 437,300,000 | 437,300,000 | 431,300,000 | 428,900,000 | 423,700,000 | 416,400,000 | 414,400,000 | 406,100,000 | 406,100,000 | 406,000,000 | 406,000,000 | 406,100,000 | 921,373,000 | 913,820,000 |
intangible assets | 300,300,000 | 308,300,000 | 291,900,000 | 295,900,000 | 294,500,000 | 297,800,000 | 296,200,000 | 303,000,000 | 272,200,000 | 278,200,000 | 276,400,000 | 278,100,000 | 287,200,000 | 282,300,000 | 284,900,000 | 398,400,000 | 410,600,000 | 417,500,000 | 424,300,000 | 435,500,000 | 419,200,000 | 431,300,000 | 441,900,000 | 455,800,000 | 464,700,000 | 476,300,000 | 486,800,000 | 443,600,000 | 435,400,000 | 443,400,000 | 443,200,000 | 443,400,000 | 396,100,000 | 403,100,000 | 405,100,000 | 404,800,000 | 404,400,000 | 411,300,000 | 410,100,000 | 414,200,000 | 415,800,000 | 419,400,000 | 324,700,000 | 325,500,000 | 99,900,000 | 103,300,000 | 89,600,000 | 88,200,000 | 87,300,000 | 86,800,000 | 82,700,000 | 73,200,000 | 73,600,000 | 46,500,000 | 45,200,000 | 35,500,000 | 35,700,000 | 44,500,000 | 23,600,000 | 25,000,000 | 27,200,000 | 28,400,000 | 29,500,000 | 46,780,000 | 50,408,000 |
other long-term assets | 244,400,000 | 243,700,000 | 257,400,000 | 232,900,000 | 209,500,000 | 219,200,000 | 210,900,000 | 208,400,000 | 178,700,000 | 191,600,000 | 209,800,000 | 219,700,000 | 226,700,000 | 222,000,000 | 206,600,000 | 226,300,000 | 223,300,000 | 254,500,000 | 263,100,000 | 269,700,000 | 274,400,000 | 295,000,000 | 305,900,000 | 305,300,000 | 303,700,000 | 304,700,000 | 308,800,000 | 296,900,000 | 292,500,000 | 291,000,000 | 296,000,000 | 258,500,000 | 239,100,000 | 235,100,000 | 245,300,000 | 237,900,000 | 244,300,000 | 221,300,000 | 213,900,000 | 206,800,000 | 205,800,000 | 197,000,000 | 222,100,000 | 191,600,000 | 169,500,000 | 148,000,000 | 151,400,000 | 144,100,000 | 130,800,000 | 138,100,000 | 144,900,000 | 135,400,000 | 130,700,000 | 125,000,000 | 93,200,000 | 97,500,000 | 85,200,000 | 69,700,000 | 69,800,000 | 76,700,000 | 88,900,000 | 97,200,000 | 120,000,000 | 414,942,000 | 412,862,000 |
total assets | 7,313,200,000 | 7,089,700,000 | 6,865,700,000 | 6,785,700,000 | 6,641,300,000 | 6,534,700,000 | 6,458,400,000 | 6,388,700,000 | 6,231,400,000 | 6,102,400,000 | 5,964,300,000 | 5,860,900,000 | 5,747,300,000 | 5,636,500,000 | 5,475,900,000 | 7,082,200,000 | 6,944,000,000 | 6,864,900,000 | 6,721,700,000 | 6,612,900,000 | 6,542,200,000 | 6,445,900,000 | 6,610,500,000 | 6,502,500,000 | 6,137,700,000 | 6,080,700,000 | 6,386,800,000 | 5,812,100,000 | 5,583,800,000 | 5,175,000,000 | 5,131,900,000 | 5,089,400,000 | 4,939,600,000 | 4,893,700,000 | 4,883,400,000 | 4,840,000,000 | 4,703,800,000 | 4,681,900,000 | 4,631,300,000 | 4,632,600,000 | 4,608,300,000 | 4,606,100,000 | 4,249,300,000 | 3,469,500,000 | 2,794,000,000 | 2,576,500,000 | 2,539,100,000 | 2,534,400,000 | 2,556,500,000 | 2,511,700,000 | 2,392,300,000 | 2,423,800,000 | 2,456,200,000 | 2,481,100,000 | 1,796,900,000 | 1,756,100,000 | 1,716,100,000 | 1,980,500,000 | 1,965,100,000 | 2,012,000,000 | 2,528,900,000 | 2,402,400,000 | 3,237,800,000 | 3,285,144,000 | 3,310,549,000 |
liabilities and shareholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of long-term debt | 42,900,000 | 43,600,000 | 39,000,000 | 139,200,000 | 138,700,000 | 138,600,000 | 233,000,000 | 32,500,000 | 25,600,000 | 24,800,000 | 23,900,000 | 22,800,000 | 26,000,000 | 25,200,000 | 26,200,000 | 49,200,000 | 42,800,000 | 42,800,000 | 65,900,000 | 66,800,000 | 137,200,000 | 38,300,000 | 37,000,000 | 36,900,000 | 40,200,000 | 39,300,000 | 437,200,000 | 38,100,000 | 37,300,000 | 35,800,000 | 37,100,000 | 36,000,000 | 32,700,000 | 32,300,000 | 31,100,000 | 38,300,000 | 37,900,000 | 37,100,000 | 36,800,000 | 36,500,000 | 36,600,000 | 36,800,000 | 23,600,000 | 21,400,000 | 208,500,000 | 12,300,000 | 13,600,000 | 16,200,000 | 21,500,000 | 21,500,000 | 56,000,000 | 56,700,000 | 61,600,000 | 40,900,000 | 40,700,000 | 44,000,000 | 59,285,000 | 60,164,000 | |||||||
current operating lease liabilities | 26,900,000 | 26,500,000 | 25,900,000 | 25,500,000 | 26,700,000 | 26,300,000 | 26,500,000 | 26,600,000 | 25,400,000 | 24,100,000 | 24,900,000 | 26,100,000 | 26,300,000 | 25,600,000 | 22,700,000 | 36,700,000 | 38,400,000 | 38,400,000 | 40,700,000 | 42,000,000 | 44,200,000 | 44,800,000 | 47,100,000 | 42,200,000 | 40,800,000 | 40,400,000 | 44,900,000 | 45,200,000 | 48,300,000 | ||||||||||||||||||||||||||||||||||||
accounts payable | 204,000,000 | 178,200,000 | 138,400,000 | 174,500,000 | 159,100,000 | 171,000,000 | 170,300,000 | 164,200,000 | 166,100,000 | 170,000,000 | 165,400,000 | 155,800,000 | 141,100,000 | 132,900,000 | 134,100,000 | 138,300,000 | 147,300,000 | 137,600,000 | 149,400,000 | 145,100,000 | 122,800,000 | 115,000,000 | 119,600,000 | 93,100,000 | 98,000,000 | 94,600,000 | 101,400,000 | 95,600,000 | 94,700,000 | 90,000,000 | 86,000,000 | 85,600,000 | 83,100,000 | 78,400,000 | 81,800,000 | 77,500,000 | 68,900,000 | 68,300,000 | 67,500,000 | 67,100,000 | 62,700,000 | 61,600,000 | 65,600,000 | 60,000,000 | 54,800,000 | 55,700,000 | 48,500,000 | 61,900,000 | 54,200,000 | 57,300,000 | 61,200,000 | 45,300,000 | 51,900,000 | 50,800,000 | 49,300,000 | 47,300,000 | 47,200,000 | 40,600,000 | 47,700,000 | 46,000,000 | 50,100,000 | 58,700,000 | 62,500,000 | 117,086,000 | 100,206,000 |
accrued expenses and other current liabilities | 603,000,000 | 558,700,000 | 525,900,000 | 531,500,000 | 467,600,000 | 471,200,000 | 463,200,000 | 425,000,000 | 416,200,000 | 366,900,000 | 421,600,000 | 611,200,000 | 526,000,000 | 537,900,000 | 550,600,000 | 508,000,000 | 478,800,000 | 492,200,000 | 407,200,000 | 525,100,000 | 574,000,000 | 587,900,000 | 486,500,000 | 452,300,000 | 456,200,000 | 398,300,000 | 377,500,000 | 380,500,000 | 371,700,000 | 355,500,000 | 364,500,000 | 314,400,000 | 283,200,000 | 251,400,000 | 243,600,000 | 253,500,000 | 257,600,000 | 254,300,000 | 255,800,000 | 325,900,000 | 287,100,000 | 324,500,000 | 322,600,000 | 324,100,000 | 360,700,000 | 342,500,000 | 396,300,000 | 364,500,000 | 307,500,000 | 405,000,000 | 469,019,000 | 394,318,000 | |||||||||||||
total current liabilities | 876,800,000 | 836,400,000 | 762,000,000 | 865,100,000 | 856,000,000 | 841,000,000 | 897,400,000 | 694,500,000 | 680,300,000 | 656,400,000 | 639,200,000 | 655,000,000 | 592,100,000 | 575,900,000 | 604,700,000 | 835,400,000 | 754,500,000 | 748,800,000 | 793,900,000 | 804,500,000 | 812,200,000 | 717,300,000 | 682,500,000 | 664,400,000 | 586,200,000 | 721,000,000 | 1,108,600,000 | 752,900,000 | 768,200,000 | 672,500,000 | 609,600,000 | 573,900,000 | 572,000,000 | 517,500,000 | 511,200,000 | 493,300,000 | 487,300,000 | 475,600,000 | 476,000,000 | 459,100,000 | 463,800,000 | 426,400,000 | 403,600,000 | 364,600,000 | 514,700,000 | 299,300,000 | 302,000,000 | 311,600,000 | 311,800,000 | 311,600,000 | 317,000,000 | 300,900,000 | 377,800,000 | 337,900,000 | 390,000,000 | 391,400,000 | 392,800,000 | 860,100,000 | 839,800,000 | 911,900,000 | 1,019,500,000 | 1,145,600,000 | 1,247,100,000 | 1,138,583,000 | 1,037,716,000 |
long-term debt | 2,530,900,000 | 2,447,200,000 | 2,393,900,000 | 2,320,300,000 | 2,333,200,000 | 2,359,200,000 | 2,344,500,000 | 2,684,100,000 | 2,682,600,000 | 2,687,800,000 | 2,692,700,000 | 2,697,600,000 | 2,722,500,000 | 2,741,800,000 | 2,719,000,000 | 3,233,500,000 | 3,221,300,000 | 3,243,900,000 | 3,142,000,000 | 3,105,700,000 | 3,160,000,000 | 3,250,600,000 | 3,539,400,000 | 3,546,700,000 | 3,321,900,000 | 3,023,300,000 | 2,961,900,000 | 2,719,600,000 | 2,521,800,000 | 2,478,600,000 | 2,503,900,000 | 2,600,500,000 | 2,544,400,000 | 2,545,400,000 | 2,591,300,000 | 2,625,100,000 | 2,915,500,000 | 2,979,300,000 | 2,974,000,000 | 3,050,000,000 | 3,079,600,000 | 3,134,700,000 | 2,800,700,000 | 2,104,400,000 | 1,441,400,000 | 1,475,100,000 | 1,503,100,000 | 1,505,200,000 | 1,306,200,000 | 1,319,700,000 | 1,365,300,000 | 1,239,900,000 | 1,242,300,000 | 1,550,800,000 | 1,639,100,000 | 1,633,000,000 | 1,635,800,000 | 1,820,800,000 | 1,827,400,000 | 1,989,000,000 | 2,351,900,000 | 2,360,000,000 | 3,294,500,000 | 3,254,164,000 | 3,273,843,000 |
long-term operating lease liabilities | 188,700,000 | 196,600,000 | 202,800,000 | 200,700,000 | 204,200,000 | 189,700,000 | 195,500,000 | 202,000,000 | 185,800,000 | 196,100,000 | 183,900,000 | 192,300,000 | 199,200,000 | 199,700,000 | 183,300,000 | 211,900,000 | 208,300,000 | 213,100,000 | 208,400,000 | 212,900,000 | 214,200,000 | 209,600,000 | 228,900,000 | 234,900,000 | 235,100,000 | 243,800,000 | 273,400,000 | 245,800,000 | 245,000,000 | ||||||||||||||||||||||||||||||||||||
deferred income tax liabilities | 135,100,000 | 126,800,000 | 107,500,000 | 110,600,000 | 114,000,000 | 105,200,000 | 97,100,000 | 91,200,000 | 93,500,000 | 87,000,000 | 80,400,000 | 83,200,000 | 87,000,000 | 83,000,000 | 46,700,000 | 79,800,000 | 89,700,000 | 86,700,000 | 60,400,000 | 61,700,000 | 60,600,000 | 51,800,000 | |||||||||||||||||||||||||||||||||||||||||||
other long-term liabilities | 214,500,000 | 53,800,000 | 213,200,000 | 200,800,000 | 196,300,000 | 51,800,000 | 198,300,000 | 186,900,000 | 185,800,000 | 46,100,000 | 178,900,000 | 175,800,000 | 183,300,000 | 45,300,000 | 174,000,000 | 177,000,000 | 178,600,000 | 49,400,000 | 223,500,000 | 219,100,000 | 220,500,000 | 93,800,000 | 230,000,000 | 191,700,000 | 163,300,000 | 42,700,000 | 161,600,000 | 157,200,000 | 159,300,000 | 85,600,000 | 198,200,000 | 189,800,000 | 183,800,000 | 75,200,000 | 186,400,000 | 182,600,000 | 168,500,000 | 49,600,000 | 158,100,000 | 154,100,000 | 144,800,000 | 43,000,000 | 140,700,000 | 137,300,000 | 139,700,000 | 141,100,000 | 145,600,000 | 44,000,000 | 140,400,000 | 131,400,000 | 130,500,000 | 30,200,000 | 137,900,000 | 132,700,000 | 162,700,000 | 161,600,000 | 162,000,000 | 170,000,000 | 166,300,000 | 172,200,000 | 175,400,000 | 175,000,000 | 253,700,000 | 255,922,000 | 270,018,000 |
total liabilities | 3,946,000,000 | 3,813,900,000 | 3,679,400,000 | 3,697,500,000 | 3,703,700,000 | 3,685,500,000 | 3,732,800,000 | 3,858,700,000 | 3,828,000,000 | 3,805,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
redeemable noncontrolling interests | 58,800,000 | 58,300,000 | 54,400,000 | 55,100,000 | 56,100,000 | 56,500,000 | 56,500,000 | 48,600,000 | 41,100,000 | 42,000,000 | 41,500,000 | 39,300,000 | 37,500,000 | 35,600,000 | 37,800,000 | 43,300,000 | 43,200,000 | 42,200,000 | 32,500,000 | 32,900,000 | 31,700,000 | 31,600,000 | 34,000,000 | 33,400,000 | 34,000,000 | 239,600,000 | 210,000,000 | 352,800,000 | 273,000,000 | 261,700,000 | 236,500,000 | 223,900,000 | 198,600,000 | 220,900,000 | 221,300,000 | 216,000,000 | 153,400,000 | 138,300,000 | 109,400,000 | 120,000,000 | 96,200,000 | 121,100,000 | 114,100,000 | 98,500,000 | 12,200,000 | 12,400,000 | 13,000,000 | 13,500,000 | 13,900,000 | 14,100,000 | 13,800,000 | ||||||||||||||
shareholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
encompass health shareholders’ equity | 2,521,700,000 | 2,373,800,000 | 2,280,100,000 | 2,159,100,000 | 1,959,800,000 | 1,839,400,000 | 1,741,900,000 | 1,560,400,000 | 1,475,300,000 | 1,383,500,000 | 1,217,000,000 | 2,003,000,000 | 1,973,500,000 | 1,842,700,000 | 1,762,000,000 | 1,655,100,000 | 1,520,800,000 | 1,462,800,000 | 1,443,900,000 | 1,333,100,000 | 1,275,900,000 | 1,314,300,000 | 1,318,500,000 | 1,254,900,000 | 1,197,000,000 | ||||||||||||||||||||||||||||||||||||||||
noncontrolling interests | 786,700,000 | 779,300,000 | 758,100,000 | 753,000,000 | 722,400,000 | 725,700,000 | 709,300,000 | 642,000,000 | 620,400,000 | 607,700,000 | 587,300,000 | 542,400,000 | 542,200,000 | 516,000,000 | 493,000,000 | 498,300,000 | 474,900,000 | 445,700,000 | 418,300,000 | 414,100,000 | 387,900,000 | 382,000,000 | 374,900,000 | 368,600,000 | 353,300,000 | 340,900,000 | 338,200,000 | 307,900,000 | 302,200,000 | 280,300,000 | 265,200,000 | 246,400,000 | 243,800,000 | 242,900,000 | 236,800,000 | 219,300,000 | 199,400,000 | 192,800,000 | 187,500,000 | 176,700,000 | 174,400,000 | 167,900,000 | 159,800,000 | 158,800,000 | 143,200,000 | 141,700,000 | 126,600,000 | 124,100,000 | 120,900,000 | 117,900,000 | 115,200,000 | 112,500,000 | 111,300,000 | 83,900,000 | 80,100,000 | 79,000,000 | 78,000,000 | ||||||||
total shareholders’ equity | 3,308,400,000 | 3,217,500,000 | 3,131,900,000 | 3,033,100,000 | 2,881,500,000 | 2,792,700,000 | 2,669,100,000 | 2,481,400,000 | 2,362,300,000 | 2,255,200,000 | 2,147,700,000 | 2,017,700,000 | 1,925,700,000 | 1,826,300,000 | 1,710,000,000 | 2,501,300,000 | 2,448,400,000 | 2,357,000,000 | 2,261,000,000 | 2,176,100,000 | 2,043,000,000 | 1,970,000,000 | 1,895,700,000 | 1,831,400,000 | 1,797,200,000 | 1,693,100,000 | 1,671,300,000 | 1,583,800,000 | 1,616,500,000 | 1,557,000,000 | 1,583,700,000 | 1,501,300,000 | 1,440,800,000 | 1,424,600,000 | 1,373,200,000 | 1,323,000,000 | 979,100,000 | 928,700,000 | 913,800,000 | 849,400,000 | 823,900,000 | 779,300,000 | 790,200,000 | 764,700,000 | 592,800,000 | 555,400,000 | 482,200,000 | 468,700,000 | 442,000,000 | 392,700,000 | 223,500,000 | 404,100,000 | 356,000,000 | 72,300,000 | |||||||||||
total liabilities and shareholders’ equity | 7,313,200,000 | 7,089,700,000 | 6,865,700,000 | 6,785,700,000 | 6,641,300,000 | 6,534,700,000 | 6,458,400,000 | 6,388,700,000 | 6,231,400,000 | 6,102,400,000 | 5,964,300,000 | 5,860,900,000 | 5,747,300,000 | 5,636,500,000 | 5,475,900,000 | 7,082,200,000 | 6,944,000,000 | 6,864,900,000 | 6,721,700,000 | 6,612,900,000 | 6,542,200,000 | 6,445,900,000 | 6,610,500,000 | 6,502,500,000 | 6,137,700,000 | 6,080,700,000 | 6,386,800,000 | 5,812,100,000 | 5,583,800,000 | 5,175,000,000 | 5,131,900,000 | 5,089,400,000 | 4,939,600,000 | 4,893,700,000 | 4,883,400,000 | 4,840,000,000 | 4,703,800,000 | 4,681,900,000 | 4,631,300,000 | 4,632,600,000 | 4,608,300,000 | 4,606,100,000 | 4,249,300,000 | 3,469,500,000 | 2,794,000,000 | 2,576,500,000 | 2,539,100,000 | 2,534,400,000 | 2,556,500,000 | 2,511,700,000 | 2,392,300,000 | 2,423,800,000 | 2,456,200,000 | 2,481,100,000 | |||||||||||
prepaid expenses | 53,900,000 | 42,300,000 | 34,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued payroll | 243,700,000 | 227,900,000 | 207,500,000 | 168,300,000 | 265,800,000 | 253,800,000 | 210,500,000 | 188,400,000 | 172,100,000 | 147,300,000 | 126,200,000 | 90,800,000 | 85,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued distributions | 54,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other current liabilities | 289,600,000 | 238,600,000 | 187,400,000 | 181,000,000 | 219,700,000 | 218,300,000 | 303,800,000 | 333,900,000 | 210,000,000 | 197,100,000 | 172,100,000 | 122,800,000 | 130,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
self-insured risks | 153,100,000 | 138,600,000 | 131,800,000 | 128,500,000 | 123,800,000 | 121,200,000 | 117,200,000 | 119,600,000 | 110,100,000 | 110,400,000 | 101,600,000 | 98,200,000 | 106,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
encompass health shareholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock, .01 par value... | 1,200,000 | 1,200,000 | 1,200,000 | 1,100,000 | 1,100,000 | 1,100,000 | 1,100,000 | 1,100,000 | 1,100,000 | 1,100,000 | 1,100,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 4,410,000 | ||||||||||||||||||||||||||||||||||||||||||||
capital in excess of par value | 1,869,600,000 | 1,847,000,000 | 1,787,000,000 | 1,730,200,000 | 2,289,600,000 | 2,326,600,000 | 2,369,900,000 | 2,588,700,000 | 2,791,400,000 | 2,799,100,000 | 2,834,900,000 | 2,828,000,000 | 2,841,500,000 | 2,849,300,000 | 2,849,400,000 | 2,874,500,000 | 2,886,300,000 | 2,882,300,000 | 2,877,200,000 | 2,874,600,000 | 2,877,600,000 | 2,877,800,000 | 2,959,700,000 | 2,963,700,000 | 2,817,300,000 | 2,838,700,000 | 2,842,400,000 | 2,847,100,000 | 2,852,104,000 | 2,850,914,000 | |||||||||||||||||||||||||||||||||||
accumulated income | 1,289,400,000 | 796,700,000 | 406,500,000 | 115,700,000 | 141,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | 500,000 | 100,000 | -100,000 | -200,000 | -300,000 | 1,500,000 | 1,400,000 | 1,300,000 | -1,200,000 | -1,500,000 | -1,800,000 | 734,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
treasury stock | -722,500,000 | -577,900,000 | -547,200,000 | -536,700,000 | -521,200,000 | -497,400,000 | -492,300,000 | -427,900,000 | -418,500,000 | -614,700,000 | -527,400,000 | -458,100,000 | -457,600,000 | -440,300,000 | -404,600,000 | -404,200,000 | -404,000,000 | -403,100,000 | -163,300,000 | -139,200,000 | -311,400,000 | -310,600,000 | -324,200,000 | -323,400,000 | -307,868,000 | -307,302,000 | |||||||||||||||||||||||||||||||||||||||
total encompass health shareholders’ equity | 2,438,200,000 | 2,067,000,000 | 1,647,500,000 | 1,310,300,000 | 1,911,300,000 | 1,588,000,000 | 1,352,200,000 | 1,276,700,000 | 1,181,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued interest payable | 38,600,000 | 42,600,000 | 42,800,000 | 44,500,000 | 47,100,000 | 32,400,000 | 24,400,000 | 24,700,000 | 25,800,000 | 29,700,000 | 23,800,000 | 25,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued medical insurance | 34,100,000 | 31,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other current assets | 127,000,000 | 121,200,000 | 86,400,000 | 97,500,000 | 66,200,000 | 113,300,000 | 109,300,000 | 80,700,000 | 62,700,000 | 67,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
noncurrent assets of discontinued operations | 100,000 | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities of discontinued operations | 100,000 | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
noncurrent liabilities of discontinued operations | 400,000 | 400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax assets | 7,500,000 | 11,100,000 | 1,500,000 | 2,900,000 | 22,400,000 | 42,600,000 | 40,500,000 | 42,900,000 | 82,600,000 | 75,400,000 | 68,500,000 | 63,600,000 | 91,600,000 | 102,100,000 | 35,300,000 | 75,800,000 | 72,600,000 | 115,500,000 | 145,000,000 | 185,900,000 | 188,400,000 | 138,900,000 | 138,900,000 | 138,900,000 | 139,000,000 | 137,500,000 | 137,500,000 | 137,500,000 | 137,500,000 | 526,500,000 | 674,400,000 | ||||||||||||||||||||||||||||||||||
accumulated deficit | -242,300,000 | -526,500,000 | -885,200,000 | -1,191,000,000 | -1,448,400,000 | -1,696,000,000 | -1,921,200,000 | -1,971,300,000 | -2,054,400,000 | -2,101,100,000 | -2,150,000,000 | -2,208,200,000 | -2,373,400,000 | -2,424,700,000 | -3,597,600,000 | -3,629,400,000 | -3,676,700,000 | -3,994,100,000 | -4,000,700,000 | -4,044,800,000 | -4,018,900,000 | -4,306,400,000 | -4,774,700,000 | -4,642,545,000 | -4,566,401,000 | ||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -1,300,000 | -1,200,000 | -1,200,000 | -100,000 | -4,000,000 | -2,800,000 | -1,400,000 | -800,000 | -1,100,000 | -1,294,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
healthsouth shareholders’ equity | 1,136,400,000 | 1,103,700,000 | 779,700,000 | 726,300,000 | 672,700,000 | 649,500,000 | 630,400,000 | 605,900,000 | 244,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
healthsouth shareholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total healthsouth shareholders’ equity | 735,900,000 | 611,400,000 | 449,600,000 | 413,700,000 | 355,600,000 | 344,600,000 | 321,100,000 | 274,800,000 | 108,300,000 | 291,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible perpetual preferred stock, .10 par value; 1,500,000 shares authorized; zero shares issued in 2015 and 96,245 shares issued in 2014; liquidation preference of 1,000 per share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible perpetual preferred stock | 93,200,000 | 93,200,000 | 93,200,000 | 342,200,000 | 342,200,000 | 342,200,000 | 342,200,000 | 387,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible perpetual preferred stock, .10 par value; 1,500,000 shares authorized; 96,245 shares issued in 2013 and 353,355 shares issued in 2012; liquidation preference of 1,000 per share | 93,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible perpetual preferred stock, .10 par value; 1,500,000 shares authorized; 353,355 shares issued in 2012 and 400,000 shares issued in 2011; liquidation preference of 1,000 per share | 342,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25.1 in 2011; 25.9 in 2010 | 240,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
healthsouth shareholders’ deficit | -11,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33.1 in 2009 | 215,200,000 | 224,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investments in and advances to nonconsolidated affiliates | 31,600,000 | 31,000,000 | 33,400,000 | 42,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and shareholders’ deficit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible perpetual preferred stock, .10 par value; 1,500,000 shares authorized; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
400,000 issued; liquidation preference of 1,000 per share | 387,400,000 | 387,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders’ deficit: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
healthsouth shareholders' deficit: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued: 97,624,393 in 2010; 97,238,725 in 2009 | 1,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shares in 2009) | -141,700,000 | -141,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total healthsouth shareholders’ deficit | -862,400,000 | -896,300,000 | -939,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total shareholders' deficit | -782,300,000 | -817,300,000 | -861,900,000 | -1,346,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and shareholders’ deficit | 1,796,900,000 | 1,756,100,000 | 1,716,100,000 | 1,965,100,000 | 2,012,000,000 | 2,528,900,000 | 2,402,400,000 | 3,237,800,000 | 3,285,144,000 | 3,310,549,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive income | 47,200,000 | 56,300,000 | 47,700,000 | 44,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | 41,900,000 | 57,500,000 | 50,500,000 | 44,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income, net of tax: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in unrealized gain on available-for-sale securities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized net holding gain arising during the period | 700,000 | -2,600,000 | 600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reclassifications to net income | 4,600,000 | -1,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in unrealized gain on forward-starting interest rate swaps: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income before income taxes | 5,300,000 | -2,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from income tax benefit related to other comprehensive | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income items | 1,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income, net of tax | 5,300,000 | -1,200,000 | 400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive income attributable to noncontrolling interests | -10,100,000 | -10,200,000 | -9,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive income attributable to healthsouth | 37,100,000 | 46,100,000 | 37,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible perpetual preferred stock, .10 par value; 1,500,000 shares authorized; 400,000 shares issued; liquidation preference of 1,000 per share | 387,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive loss, net of tax: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized net holding loss arising during the period | -2,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive loss, net of tax | -2,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted marketable securities | 27,800,000 | 29,200,000 | 29,300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37.6 in 2007 | 226,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
insurance recoveries receivable | 230,000,000 | 230,000,000 | 230,000,000 | 230,000,000 | 230,000,000 | 230,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets held for sale | 5,200,000 | 7,900,000 | 10,200,000 | 24,200,000 | 79,700,000 | 217,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets held for sale | 27,300,000 | 20,800,000 | 21,400,000 | 87,900,000 | 172,900,000 | 794,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax refund receivable | 62,900,000 | 43,200,000 | 48,700,000 | 453,700,000 | 208,900,000 | 207,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and shareholders' deficit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
government, class action, and related settlements | 367,700,000 | 353,300,000 | 365,000,000 | 429,300,000 | 454,000,000 | 523,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities held for sale | 35,100,000 | 39,600,000 | 43,000,000 | 134,700,000 | 271,800,000 | 196,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities held for sale | 3,700,000 | 3,800,000 | 4,100,000 | 6,600,000 | 13,400,000 | 44,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interest in equity of consolidated affiliates | 84,700,000 | 87,900,000 | 85,700,000 | 93,600,000 | 109,800,000 | 262,500,000 | 299,030,000 | 292,909,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
400,000 issued in 2008 and 2007; liquidation preference of 1,000 per share | 387,400,000 | 387,400,000 | 387,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders' deficit: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued: 96,890,424 in 2008; 87,514,378 in 2007 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and shareholders' deficit | 1,980,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37.8 in 2007 | 240,900,000 | 240,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in and advances to nonconsolidated affiliates | 41,700,000 | 42,700,000 | 41,300,000 | 40,100,000 | 39,600,000 | 58,607,000 | 55,721,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued: 96,883,924 in 2008; 87,514,378 in 2007 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
in 2007) | -310,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total shareholders’ deficit | -1,347,500,000 | -1,538,300,000 | -1,505,500,000 | -1,788,800,000 | -2,252,000,000 | -2,096,809,000 | -2,019,789,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net operating revenues | 461,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
salaries and benefits | 236,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other operating expenses | 65,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
general and administrative expenses | 25,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplies | 28,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 18,300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets | 600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
occupancy costs | 12,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 6,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on disposal of assets | 800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
professional fees—accounting, tax, and legal | 5,300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total operating expenses | 390,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on early extinguishment of debt | 3,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest expense and amortization of debt discounts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and fees | 43,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other income | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on interest rate swap | -28,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in net income of nonconsolidated affiliates | -2,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interests in earnings of consolidated affiliates | 8,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations before | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | 47,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from income tax benefit | 700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations | 47,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
of income tax benefit | -3,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible perpetual preferred stock dividends | -6,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income available to common shareholders | 37,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
foreign currency translation adjustment | 800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities | -400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 79,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 93,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted earnings per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
to common shareholders | 510,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net of income tax benefit | -40,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders | 470,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued: 87,886,328 in 2008; 87,514,378 in 2007 | 900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of restricted cash | 53,200,000 | 50,900,000 | 53,800,000 | 120,833,000 | 161,643,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of restricted marketable securities | 17,500,000 | 16,800,000 | 16,400,000 | 10,292,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
35.3 in 2006 | 229,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
400,000 issued in 2007 and 2006; liquidation preference of 1,000 per share | 387,400,000 | 387,400,000 | 387,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued: 88,112,764 in 2007; 87,999,513 in 2006 | 900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2006) | -325,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
notes receivable from shareholders, officers, and management employees | -100,000 | -116,000 | -116,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36.6 in 2006 | 215,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
refunds due patients and other third-party payors | 12,900,000 | 15,600,000 | 113,113,000 | 122,008,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued: 88,094,777 in 2007; 87,999,513 in 2006 | 900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36.4 in 2006 | 224,300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued: 88,086,727 in 2007; 87,999,513 in 2006 | 900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
marketable securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of government, class action, and related settlements | 380,080,000 | 361,020,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
government, class action, and related settlements, net of current portion | 46,851,000 | 68,449,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible perpetual preferred stock, .10 par value; 1,500,000 shares authorized; issued: 400,000 in 2006; none issued and outstanding in 2005; liquidation preference of 1,000 per share | 387,403,000 | 387,403,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
88,201,204 in 2006; 88,100,795 in 2005 | 882,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2011-03-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | 248,200,000 | 203,100,000 | 174,600,000 | 184,900,000 | 196,500,000 | 164,200,000 | 147,100,000 | 146,500,000 | 138,800,000 | 119,100,000 | 113,400,000 | 117,200,000 | 113,300,000 | 117,500,000 | 67,000,000 | 71,300,000 | 110,100,000 | 115,700,000 | 126,700,000 | 142,000,000 | 132,800,000 | 111,700,000 | 100,100,000 | 48,300,000 | 108,700,000 | 125,200,000 | 105,200,000 | 76,700,000 | 64,800,000 | 97,900,000 | 61,500,000 | 72,300,000 | 179,000,000 | 65,900,000 | 59,300,000 | 91,500,000 | 41,900,000 | 57,500,000 | 50,500,000 | |||||||||||||||||||||||||
loss from discontinued operations, net of tax | -15,900,000 | -800,000 | 400,000 | 900,000 | 500,000 | -400,000 | 700,000 | 1,200,000 | 1,300,000 | 8,500,000 | 1,300,000 | 1,200,000 | 1,000,000 | 0 | 100,000 | 100,000 | 500,000 | 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 87,300,000 | 86,400,000 | 82,400,000 | 79,900,000 | 79,200,000 | 78,000,000 | 78,400,000 | 72,900,000 | 70,300,000 | 70,100,000 | 67,300,000 | 72,600,000 | 63,900,000 | 63,300,000 | 45,300,000 | 68,800,000 | 66,200,000 | 65,800,000 | 64,900,000 | 63,400,000 | 62,500,000 | 62,300,000 | 61,200,000 | 60,700,000 | 58,800,000 | 52,500,000 | 45,900,000 | 42,400,000 | 27,400,000 | 26,400,000 | 26,400,000 | 24,300,000 | 23,100,000 | 22,100,000 | 21,700,000 | 20,300,000 | 19,300,000 | 18,700,000 | 18,300,000 | |||||||||||||||||||||||||
stock-based compensation | 11,500,000 | 18,400,000 | 14,300,000 | 14,300,000 | 9,500,000 | 12,500,000 | 12,900,000 | 13,600,000 | 9,300,000 | 13,400,000 | 13,700,000 | 15,600,000 | 7,900,000 | 8,100,000 | 4,800,000 | 8,800,000 | 7,500,000 | 11,100,000 | 6,900,000 | 12,000,000 | 2,800,000 | 4,200,000 | 8,300,000 | 9,900,000 | 7,100,000 | 19,400,000 | 26,100,000 | 4,500,000 | 5,000,000 | 7,000,000 | 7,300,000 | 6,200,000 | 6,500,000 | 6,300,000 | 6,000,000 | 4,200,000 | 3,400,000 | 4,000,000 | 3,800,000 | |||||||||||||||||||||||||
deferred tax expense | 8,500,000 | 19,100,000 | -2,100,000 | -3,500,000 | 8,800,000 | 8,600,000 | -2,100,000 | -2,300,000 | 6,500,000 | -3,700,000 | 4,000,000 | 35,600,000 | 200,000 | -9,900,000 | 2,000,000 | 23,400,000 | -1,800,000 | -2,500,000 | 8,700,000 | 58,100,000 | 3,400,000 | -10,500,000 | 1,400,000 | 2,600,000 | -3,000,000 | 34,700,000 | 29,200,000 | 31,700,000 | 22,300,000 | |||||||||||||||||||||||||||||||||||
loss on investments | -16,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other | 2,300,000 | -4,600,000 | 0 | -1,200,000 | 2,300,000 | 1,200,000 | -700,000 | -700,000 | 14,900,000 | -5,600,000 | 7,700,000 | 1,900,000 | 1,200,000 | 10,600,000 | -12,300,000 | 14,100,000 | 7,900,000 | -8,000,000 | -4,200,000 | 2,000,000 | 2,000,000 | -9,600,000 | 7,700,000 | 100,000 | 7,700,000 | 14,200,000 | -2,000,000 | -4,000,000 | -800,000 | 16,000,000 | -1,600,000 | -6,800,000 | 1,600,000 | 6,100,000 | -1,000,000 | -900,000 | -800,000 | 3,400,000 | -500,000 | -8,700,000 | 5,900,000 | -8,700,000 | 500,000 | 6,900,000 | 3,000,000 | 3,100,000 | 5,700,000 | -500,000 | 800,000 | 5,300,000 | 900,000 | -3,300,000 | 1,000,000 | 1,700,000 | 100,000 | 600,000 | -100,000 | 1,100,000 | 800,000 | 300,000 | ||||
change in assets and liabilities, net of acquisitions— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | -53,200,000 | 3,600,000 | -3,100,000 | 9,000,000 | -24,700,000 | -26,100,000 | 28,200,000 | 8,600,000 | -7,700,000 | -43,100,000 | 9,200,000 | -12,200,000 | 23,700,000 | -39,300,000 | -7,400,000 | 22,500,000 | 7,300,000 | -27,600,000 | 1,400,000 | 17,000,000 | -55,100,000 | 33,700,000 | -33,300,000 | -1,900,000 | -36,600,000 | -29,600,000 | 8,300,000 | -45,700,000 | -13,100,000 | -10,900,000 | -24,700,000 | 12,300,000 | -14,500,000 | -24,300,000 | -9,000,000 | -21,400,000 | 5,300,000 | 3,400,000 | -21,300,000 | |||||||||||||||||||||||||
other assets | -11,600,000 | -3,000,000 | -17,200,000 | 700,000 | 5,100,000 | -32,400,000 | -16,000,000 | 4,300,000 | -4,700,000 | -3,700,000 | 2,800,000 | -9,800,000 | 12,000,000 | -9,800,000 | -18,500,000 | 1,300,000 | -2,700,000 | 4,200,000 | 15,800,000 | -3,800,000 | 14,200,000 | 1,800,000 | 500,000 | 13,100,000 | -4,700,000 | -3,800,000 | -2,100,000 | 1,400,000 | -13,900,000 | 3,500,000 | -3,700,000 | -2,100,000 | ||||||||||||||||||||||||||||||||
accounts payable | -2,000,000 | 10,100,000 | -30,200,000 | -400,000 | -2,100,000 | 1,600,000 | -400,000 | 5,600,000 | -3,800,000 | 12,000,000 | -4,200,000 | 2,800,000 | 1,200,000 | 2,600,000 | -4,200,000 | 6,100,000 | 2,200,000 | 3,300,000 | 10,700,000 | 1,300,000 | 600,000 | 1,000,000 | 100,000 | 2,600,000 | 400,000 | -2,600,000 | 12,100,000 | -5,800,000 | 1,900,000 | 1,900,000 | 100,000 | -2,900,000 | ||||||||||||||||||||||||||||||||
other liabilities | 33,000,000 | -13,400,000 | 47,500,000 | 4,700,000 | 18,600,000 | -900,000 | 21,400,000 | 6,400,000 | 25,900,000 | -21,900,000 | 3,200,000 | 17,600,000 | 16,700,000 | -17,300,000 | -38,300,000 | 64,300,000 | 400,000 | -9,400,000 | 10,600,000 | 12,500,000 | -2,200,000 | 15,100,000 | -10,000,000 | 29,600,000 | -109,600,000 | 11,700,000 | 26,400,000 | 4,100,000 | 12,400,000 | -19,900,000 | -100,000 | -400,000 | -4,000,000 | -2,200,000 | 5,900,000 | 8,600,000 | 8,200,000 | 7,800,000 | 16,600,000 | |||||||||||||||||||||||||
net cash from operating activities of discontinued operations | 21,200,000 | 1,100,000 | -600,000 | -1,200,000 | -700,000 | 600,000 | -1,000,000 | -2,000,000 | -700,000 | -11,400,000 | -1,700,000 | -1,600,000 | -1,300,000 | -3,700,000 | -100,000 | 100,000 | 0 | 0 | -100,000 | 0 | -100,000 | -3,000,000 | -700,000 | -200,000 | 200,000 | -1,000,000 | -200,000 | -1,200,000 | 500,000 | -700,000 | 500,000 | -1,400,000 | -1,300,000 | -2,000,000 | -2,200,000 | |||||||||||||||||||||||||||||
total adjustments | 80,800,000 | 143,700,000 | 95,800,000 | 84,400,000 | 91,600,000 | 115,000,000 | 120,000,000 | 69,700,000 | 98,700,000 | 73,400,000 | 100,500,000 | 88,300,000 | 113,600,000 | 53,200,000 | 19,800,000 | 173,300,000 | 108,800,000 | 8,100,000 | 50,800,000 | 113,600,000 | 25,700,000 | 168,000,000 | 73,300,000 | 174,100,000 | -79,500,000 | 34,200,000 | 110,600,000 | 82,900,000 | 73,900,000 | 33,900,000 | 45,500,000 | 69,400,000 | -73,500,000 | 55,100,000 | 51,900,000 | 12,000,000 | 54,300,000 | 30,500,000 | 31,200,000 | |||||||||||||||||||||||||
net cash from operating activities | 313,100,000 | 346,000,000 | 270,800,000 | 270,200,000 | 288,600,000 | 278,800,000 | 267,800,000 | 217,400,000 | 238,800,000 | 201,000,000 | 215,200,000 | 206,700,000 | 227,900,000 | 172,200,000 | 70,100,000 | 244,600,000 | 218,900,000 | 123,800,000 | 177,600,000 | 255,900,000 | 158,500,000 | 279,700,000 | 173,400,000 | 222,300,000 | 29,300,000 | 679,000,000 | -5,500,000 | -198,100,000 | 159,900,000 | 778,800,000 | -2,600,000 | -230,100,000 | 216,300,000 | 610,200,000 | 14,400,000 | -12,500,000 | 45,100,000 | 527,700,000 | 46,300,000 | -128,200,000 | 159,700,000 | -338,600,000 | 382,200,000 | 139,600,000 | 128,000,000 | 107,100,000 | 142,600,000 | 105,400,000 | 121,400,000 | 109,300,000 | 89,100,000 | 96,800,000 | 87,900,000 | 84,800,000 | 82,300,000 | 25,200,000 | 41,800,000 | 376,300,000 | -34,600,000 | -105,200,000 | -5,800,000 | -25,071,000 | 20,749,000 | -71,313,000 |
cash flows from investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property, equipment, and intangible assets | -162,400,000 | -229,300,000 | -187,100,000 | -156,900,000 | -163,100,000 | -198,700,000 | -147,500,000 | -156,900,000 | -139,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of restricted investments | 42,900,000 | 12,800,000 | 28,000,000 | 121,000,000 | 11,000,000 | 1,000,000 | 900,000 | 1,000,000 | 16,000,000 | 6,600,000 | 300,000 | 400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of restricted investments | -26,400,000 | -18,500,000 | -38,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities | -150,100,000 | -239,400,000 | -201,300,000 | -165,400,000 | -158,500,000 | -203,700,000 | -161,500,000 | -158,400,000 | -129,700,000 | -208,100,000 | -162,200,000 | -128,500,000 | -104,000,000 | -206,400,000 | -174,300,000 | -123,200,000 | -123,100,000 | -220,700,000 | -124,000,000 | -226,000,000 | -95,600,000 | -142,700,000 | -89,700,000 | -92,100,000 | -83,000,000 | -381,800,000 | -268,000,000 | 83,900,000 | -91,500,000 | -322,600,000 | 29,700,000 | -71,000,000 | -60,600,000 | -268,300,000 | 800,000 | -4,100,000 | -12,900,000 | -227,100,000 | -17,600,000 | 39,200,000 | -39,500,000 | -780,800,000 | -111,600,000 | -55,300,000 | -39,200,000 | -67,800,000 | -95,800,000 | -53,500,000 | -47,900,000 | -54,500,000 | -23,400,000 | -56,700,000 | -13,500,000 | -26,200,000 | -51,500,000 | 6,500,000 | 33,100,000 | -3,400,000 | 44,700,000 | 1,080,000,000 | 63,200,000 | 19,547,000 | -15,361,000 | 48,948,000 |
cash flows from financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
borrowings on revolving credit facility | 420,000,000 | 70,000,000 | 80,000,000 | 0 | 60,000,000 | 30,000,000 | 0 | 0 | 50,000,000 | 0 | 0 | 30,000,000 | 30,000,000 | 60,000,000 | -120,000,000 | 170,000,000 | 130,000,000 | 190,000,000 | 65,000,000 | 0 | 0 | 0 | 330,000,000 | 110,000,000 | 125,000,000 | 375,000,000 | 25,000,000 | 40,000,000 | 40,000,000 | 150,000,000 | 95,000,000 | 32,000,000 | 136,300,000 | 50,000,000 | 55,000,000 | 75,000,000 | 95,000,000 | 105,000,000 | 60,000,000 | 225,000,000 | 45,000,000 | 0 | 25,000,000 | 40,000,000 | 15,000,000 | 10,000,000 | 122,000,000 | 0 | 40,000,000 | 13,000,000 | 60,000,000 | 15,000,000 | 85,000,000 | 165,000,000 | 10,000,000 | 0 | 0 | 50,000,000 | ||||||
payments on revolving credit facility | -330,000,000 | -20,000,000 | 0 | 0 | -80,000,000 | -10,000,000 | 0 | 0 | -50,000,000 | 0 | 0 | -70,000,000 | -45,000,000 | -45,000,000 | -10,000,000 | -305,000,000 | -25,000,000 | -80,000,000 | 0 | 0 | -350,000,000 | -25,000,000 | -65,000,000 | -460,000,000 | -65,000,000 | -30,000,000 | -75,000,000 | -125,000,000 | -95,000,000 | -95,000,000 | -75,000,000 | -68,300,000 | -65,000,000 | -122,000,000 | -73,000,000 | -95,000,000 | -85,000,000 | -60,000,000 | -120,000,000 | -173,000,000 | -15,000,000 | -53,000,000 | -42,000,000 | -53,000,000 | 0 | -107,000,000 | 0 | -35,000,000 | -240,000,000 | -40,000,000 | ||||||||||||||
repurchases of common stock, including fees and expenses | -71,600,000 | -76,300,000 | -24,900,000 | -24,700,000 | -32,100,000 | -7,500,000 | -6,800,000 | -1,200,000 | 0 | 0 | -2,100,000 | 0 | -20,000,000 | 0 | -18,100,000 | -41,500,000 | 0 | -11,200,000 | -12,900,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
dividends paid on common stock | -20,300,000 | -19,000,000 | -17,000,000 | -17,100,000 | -18,000,000 | -17,000,000 | -15,000,000 | -14,900,000 | -15,900,000 | -14,900,000 | -15,000,000 | -14,900,000 | -15,600,000 | -14,900,000 | -27,800,000 | -27,800,000 | -28,500,000 | -27,700,000 | -27,800,000 | -27,800,000 | -29,100,000 | -27,600,000 | -27,600,000 | -27,700,000 | -29,000,000 | -27,500,000 | -26,400,000 | -26,500,000 | -28,300,000 | -26,500,000 | -24,500,000 | -24,400,000 | -25,400,000 | -24,500,000 | -23,500,000 | -21,300,000 | -22,200,000 | -21,400,000 | -20,500,000 | -20,600,000 | -21,300,000 | -20,900,000 | -19,200,000 | -15,800,000 | -15,800,000 | -15,800,000 | ||||||||||||||||||
distributions paid to noncontrolling interests of consolidated affiliates | -57,800,000 | -42,700,000 | -36,100,000 | -40,400,000 | -32,900,000 | -39,500,000 | -33,000,000 | -27,800,000 | -24,700,000 | -22,800,000 | -32,500,000 | -27,600,000 | -31,800,000 | -28,400,000 | -21,600,000 | -25,300,000 | -21,300,000 | -25,100,000 | -25,100,000 | -24,900,000 | -27,800,000 | -19,300,000 | -15,500,000 | -18,300,000 | -19,100,000 | -19,500,000 | -15,400,000 | -15,600,000 | -14,200,000 | -13,400,000 | -12,000,000 | -10,200,000 | -10,700,000 | -13,200,000 | -11,700,000 | -11,100,000 | ||||||||||||||||||||||||||||
taxes paid on behalf of employees for shares withheld | -30,900,000 | -100,000 | 0 | -100,000 | -19,800,000 | 0 | 0 | 0 | -12,100,000 | -100,000 | -400,000 | 0 | -7,700,000 | -100,000 | 500,000 | -100,000 | -7,600,000 | 0 | 0 | -800,000 | -15,600,000 | 0 | 0 | -100,000 | -15,600,000 | -1,600,000 | -100,000 | 1,000,000 | -15,900,000 | -900,000 | 0 | -300,000 | 0 | -12,900,000 | -6,600,000 | |||||||||||||||||||||||||||||
net cash from financing activities | -102,500,000 | -97,400,000 | -113,200,000 | -90,200,000 | -130,400,000 | -150,900,000 | -89,500,000 | -49,600,000 | -40,600,000 | -29,900,000 | -65,800,000 | -43,500,000 | -58,000,000 | -16,500,000 | -49,000,000 | -19,300,000 | -60,900,000 | 42,300,000 | -18,500,000 | -186,400,000 | -77,500,000 | -354,200,000 | -45,600,000 | 182,800,000 | 71,100,000 | -620,800,000 | 471,100,000 | 279,600,000 | -81,700,000 | -447,200,000 | -19,300,000 | 262,000,000 | -116,700,000 | -353,800,000 | -9,600,000 | 15,000,000 | -10,400,000 | -336,600,000 | -29,100,000 | 92,700,000 | -108,600,000 | 383,800,000 | 476,400,000 | 122,200,000 | -76,100,000 | -50,700,000 | -50,500,000 | -63,300,000 | -126,200,000 | -85,200,000 | 26,900,000 | -22,200,000 | -18,700,000 | -22,700,000 | -73,000,000 | -26,000,000 | -34,400,000 | -369,800,000 | -18,900,000 | -994,000,000 | -53,900,000 | -15,213,000 | -89,766,000 | -15,809,000 |
increase in cash, cash equivalents, and restricted cash | 60,500,000 | 9,200,000 | -43,700,000 | 14,600,000 | -300,000 | -75,800,000 | 16,800,000 | 9,400,000 | 68,500,000 | -37,000,000 | -12,800,000 | 34,700,000 | 65,900,000 | 102,100,000 | 34,900,000 | -54,600,000 | 35,100,000 | -156,500,000 | -14,600,000 | -217,200,000 | 38,100,000 | 313,000,000 | 17,400,000 | -323,600,000 | 197,600,000 | 165,400,000 | -13,300,000 | 9,000,000 | 7,800,000 | -39,100,000 | 39,000,000 | |||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash at beginning of period | 102,900,000 | 0 | 0 | 0 | 123,100,000 | 0 | 0 | 0 | 104,200,000 | 0 | 0 | 0 | 53,400,000 | 0 | 0 | 0 | 120,300,000 | 0 | 0 | 0 | 310,900,000 | 0 | 0 | 0 | 159,600,000 | 92,000,000 | 0 | -92,000,000 | 133,500,000 | 82,500,000 | 0 | -82,500,000 | 116,800,000 | |||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash at end of period | 163,400,000 | 9,200,000 | -43,700,000 | 14,600,000 | 122,800,000 | -75,800,000 | 16,800,000 | 9,400,000 | 172,700,000 | -37,000,000 | -12,800,000 | 34,700,000 | 119,300,000 | -50,700,000 | -153,200,000 | 102,100,000 | 155,200,000 | -54,600,000 | 35,100,000 | -156,500,000 | 296,300,000 | -217,200,000 | 38,100,000 | 313,000,000 | 177,000,000 | -231,600,000 | 197,600,000 | 73,400,000 | 120,200,000 | 91,500,000 | 7,800,000 | -121,600,000 | 155,800,000 | |||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt-related items | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in net income of nonconsolidated affiliates | -900,000 | -300,000 | -2,400,000 | -1,900,000 | -2,600,000 | -4,300,000 | -2,000,000 | -3,300,000 | -2,900,000 | -3,000,000 | -2,500,000 | -2,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
distributions from nonconsolidated affiliates | 1,000,000 | 300,000 | 1,700,000 | 2,900,000 | 3,100,000 | 3,400,000 | 4,600,000 | 1,600,000 | 3,400,000 | 3,100,000 | 2,700,000 | 1,400,000 | 1,200,000 | 2,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of acquisitions — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued payroll | 9,500,000 | 23,000,000 | 15,100,000 | -21,900,000 | -25,400,000 | 10,500,000 | 5,600,000 | -68,100,000 | 2,600,000 | 21,700,000 | 5,700,000 | 5,300,000 | 28,300,000 | 82,400,000 | -24,000,000 | -14,800,000 | -9,500,000 | 20,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||
principal payments on debt, including pre-payments | -1,900,000 | -102,500,000 | -101,800,000 | -151,000,000 | -1,400,000 | -1,000,000 | -900,000 | -600,000 | -5,100,000 | -600,000 | -500,000 | -100,000 | -241,300,000 | -103,900,000 | -3,600,000 | -3,600,000 | -703,600,000 | -3,700,000 | -405,200,000 | -3,700,000 | -6,800,000 | -6,200,000 | -6,800,000 | -111,200,000 | -6,300,000 | -5,600,000 | -9,200,000 | -81,700,000 | -54,900,000 | -56,300,000 | -48,700,000 | -1,300,000 | -1,800,000 | -64,900,000 | -4,400,000 | -1,900,000 | -1,900,000 | -29,100,000 | ||||||||||||||||||||||||||
principal borrowings on notes | 0 | 0 | 0 | 3,800,000 | 0 | 3,050,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal payments under finance lease obligations | -6,200,000 | -6,100,000 | -5,600,000 | -5,500,000 | -5,200,000 | -26,400,000 | -4,900,000 | -2,400,000 | -33,200,000 | -6,800,000 | -5,800,000 | -5,800,000 | -19,000,000 | -200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
contributions from noncontrolling interests of consolidated affiliates | 700,000 | 106,400,000 | 14,900,000 | 18,400,000 | 13,600,000 | 8,400,000 | 29,300,000 | 17,000,000 | 9,000,000 | 12,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash at beginning of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash at end of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reconciliation of cash, cash equivalents, and restricted cash | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | -5,400,000 | 0 | 54,800,000 | 0 | 0 | 0 | 224,000,000 | 0 | 0 | 0 | 94,800,000 | 27,700,000 | 0 | -27,700,000 | 69,200,000 | 20,100,000 | 0 | -20,100,000 | 54,400,000 | 0 | 0 | 20,600,000 | 0 | -20,400,000 | 61,600,000 | 24,800,000 | 0 | 0 | 64,500,000 | 0 | 0 | 132,800,000 | 48,400,000 | 0 | 0 | 80,900,000 | 0 | 0 | 19,800,000 | -100,000 | 0 | 27,200,000 | 13,000 | 115,000 | 175,502,000 | |||||||||||||||||
restricted cash at beginning of period | 0 | 0 | -2,600,000 | 0 | 65,100,000 | 0 | 0 | 0 | 65,400,000 | 0 | 0 | 0 | 57,400,000 | 59,000,000 | 62,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of period | -30,600,000 | -38,000,000 | -126,700,000 | 92,300,000 | 94,200,000 | -40,000,000 | 21,600,000 | -150,700,000 | 223,900,000 | -226,000,000 | 31,000,000 | 314,100,000 | 104,900,000 | -296,400,000 | 197,600,000 | 137,500,000 | 56,100,000 | 27,200,000 | 7,800,000 | -52,200,000 | 86,400,000 | 5,600,000 | -1,600,000 | 42,400,000 | -400,000 | -16,700,000 | 73,200,000 | 771,800,000 | 206,500,000 | 12,700,000 | 53,100,000 | -3,700,000 | -11,400,000 | 80,100,000 | 141,000,000 | 17,900,000 | 55,800,000 | 116,800,000 | -42,300,000 | 6,800,000 | 60,400,000 | -5,100,000 | -5,200,000 | 26,200,000 | -19,689,000 | -83,438,000 | 137,294,000 | |||||||||||||||||
restricted cash at end of period | -6,400,000 | -12,700,000 | -26,500,000 | 9,800,000 | 61,000,000 | -10,800,000 | 10,900,000 | 2,800,000 | 62,200,000 | 8,200,000 | 800,000 | -300,000 | 56,700,000 | 59,000,000 | 69,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
supplemental cash flow information: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid during the year for — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental schedule of noncash investing and financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued purchases of property, equipment, and intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
joint venture contributions | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued interest payable | 19,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on early extinguishment of debt | 0 | 0 | 2,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities of discontinued operations | 100,000 | 7,900,000 | 21,255,000 | 9,961,000 | 17,597,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
debt amendment and issuance costs | -600,000 | -100,000 | 0 | -100,000 | -11,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities of discontinued operations | -1,000,000 | -400,000 | -300,000 | -800,000 | -9,000,000 | -38,500,000 | -800,000 | 7,917,000 | -755,000 | -7,769,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash included in other long-term assets at beginning of period | 0 | 0 | 0 | 400,000 | 0 | 0 | 0 | 21,500,000 | 0 | 0 | 0 | 7,400,000 | 5,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash in discontinued operations at beginning of period | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash received during the year for — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax refunds | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax payments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of restricted investments | -2,700,000 | -7,600,000 | -12,200,000 | -1,100,000 | -800,000 | -1,400,000 | -800,000 | -500,000 | -10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash included in other long-term assets at end of period | -3,800,000 | 2,600,000 | -8,600,000 | 10,200,000 | 600,000 | 6,300,000 | -800,000 | 15,400,000 | 5,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash in discontinued operations at end of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred tax benefit | 18,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
realized loss on sale of investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment | -146,700,000 | -117,200,000 | -96,600,000 | -189,900,000 | -144,900,000 | -114,800,000 | -115,200,000 | -192,600,000 | -123,600,000 | -113,900,000 | -98,800,000 | -139,800,000 | -89,600,000 | -83,100,000 | -83,500,000 | -350,100,000 | -8,700,000 | 58,700,000 | -72,300,000 | -231,200,000 | -5,300,000 | 41,900,000 | -59,900,000 | -202,300,000 | -10,400,000 | -7,900,000 | -5,200,000 | -168,500,000 | -3,800,000 | 26,000,000 | -31,400,000 | 69,300,000 | -80,100,000 | -44,400,000 | -32,900,000 | -56,600,000 | -97,800,000 | -38,900,000 | -30,100,000 | -28,300,000 | ||||||||||||||||||||||||
debt amendment costs | 0 | -20,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental schedule of noncash operating, investing, and financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment additions through finance leases | 2,100,000 | 200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued purchases of property and equipment | 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating lease additions and adjustments | 3,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of tax | 1,500,000 | 100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for government, class action, and related settlements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of businesses, net of cash acquired | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
additions to capitalized software costs | -1,700,000 | -2,600,000 | -2,800,000 | -3,000,000 | -3,000,000 | -1,300,000 | -8,500,000 | -1,300,000 | -3,900,000 | -3,400,000 | -7,100,000 | -3,800,000 | -5,300,000 | -3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from bond issuance | 400,000,000 | 0 | 0 | 0 | 700,000,000 | 0 | 120,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of equity interests in consolidated affiliates | 0 | 0 | 0 | -162,300,000 | 0 | 0 | 0 | 0 | -65,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired | -1,100,000 | 0 | 0 | -1,100,000 | -13,700,000 | 0 | -129,100,000 | -600,000 | 0 | 0 | -10,900,000 | -30,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from disposal of assets | 6,600,000 | 3,300,000 | 43,900,000 | 796,000 | 2,438,000 | 5,441,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in cash, cash equivalents, and restricted cash | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental schedule of noncash operating, investing and financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contributions from consolidated affiliates | 21,400,000 | 0 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating lease additions | 5,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on consolidation of yuma rehabilitation hospital | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents. and restricted cash at beginning of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental schedule of noncash financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adoption of asc 842 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
debt issuance costs | -1,490,000 | -10,967,000 | -66,720,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental schedule of noncash financing activity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercising stock warrants | 0 | 0 | 0 | 26,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
conversion of convertible debt | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
funding of intercompany note receivable | -56,000,000 | -5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from repayment of intercompany note receivable | 17,500,000 | 40,000,000 | 16,000,000 | 10,000,000 | 7,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal borrowings on intercompany note payable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal payments on intercompany note payable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
change in intercompany advances | 34,200,000 | 93,800,000 | 79,000,000 | 70,300,000 | 82,300,000 | 72,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash included in other long term assets at beginning of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of acquisitions— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal payments under capital lease obligations | -1,900,000 | -3,200,000 | -3,700,000 | -3,500,000 | -3,700,000 | -3,500,000 | -3,700,000 | -3,600,000 | -3,500,000 | -3,300,000 | -3,100,000 | -3,200,000 | -5,155,000 | -4,841,000 | -4,789,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
intercompany note activity | -1,600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash, at beginning of period | 116,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash, at end of period | 155,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for doubtful accounts | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
premium received on bond issuance | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
premium paid on redemption of bonds | -1,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of nonrestricted marketable securities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in restricted cash | -3,200,000 | -8,600,000 | -21,600,000 | 10,100,000 | 10,000,000 | 29,500,000 | -11,400,000 | 17,900,000 | -900,000 | -2,300,000 | -4,600,000 | 14,000,000 | 50,308,000 | 51,408,000 | 14,859,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
principal borrowings on term loan facilities | 125,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents | -11,900,000 | 5,600,000 | -1,600,000 | 21,800,000 | -36,000,000 | -400,000 | 3,700,000 | 11,600,000 | 206,500,000 | -3,700,000 | -11,400,000 | -52,700,000 | -30,400,000 | 92,600,000 | 17,900,000 | 55,700,000 | 35,900,000 | -42,200,000 | 6,500,000 | 40,500,000 | 3,600,000 | |||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock conversion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on consolidation of fairlawn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
windfall tax benefits from share-based compensation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of marketable securities | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
dividends paid on convertible perpetual preferred stock | 0 | 0 | -1,600,000 | -1,500,000 | -1,600,000 | -5,700,000 | -5,800,000 | -5,700,000 | -5,700,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | -6,500,000 | 0 | -6,500,000 | |||||||||||||||||||||||||||||||||||||||||||||
equity rollover from encompass management | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
capitalized software costs | -8,300,000 | 100,000 | -7,700,000 | -3,800,000 | -6,800,000 | -1,600,000 | -4,000,000 | -7,000,000 | -3,700,000 | -3,800,000 | -8,100,000 | -3,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 16,500,000 | 8,200,000 | 9,300,000 | 7,500,000 | 8,000,000 | 7,000,000 | 7,400,000 | 5,400,000 | 4,300,000 | 5,900,000 | 6,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
change in assets and liabilities— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in cash and cash equivalents | -11,400,000 | 3,100,000 | -8,800,000 | -20,298,000 | -84,090,000 | -38,585,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental schedule of noncash investing activity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
conversion of preferred stock to common stock | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss from discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on consolidation of fairlawn rehabilitation hospital | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
debt amendment and issue costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(income) income from discontinued operations | 900,000 | -14,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from government, class action, and related settlements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in assets— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in liabilities— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of business, net of cash acquired | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of digital hospital | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | 100,000 | 400,000 | 600,000 | -100,000 | 3,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
escrow deposit — acquisition of business | -11,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of common stock, including fees and expenses | -26,300,000 | 0 | -1,500,000 | -232,600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of stock warrants | 6,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss (income) from discontinued operations | 900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred tax (benefit) expense | 32,700,000 | -3,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
government, class action, and related settlements | 0 | -4,300,000 | 0 | 0 | -800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of convertible perpetual preferred stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
debt issue costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercising stock options | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on interest rate swaps | 9,000,000 | -300,000 | 4,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in assets— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued interest | 10,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
refunds due patients and other third-party payors | -600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
termination of forward-starting interest rate swaps designated as cash flow hedges | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net settlements on interest rate swaps not designated as hedges | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities of discontinued operations— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of ltchs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other investing activities of discontinued operations | 0 | -800,000 | -700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal borrowings on term loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchases of convertible perpetual preferred stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt discounts | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
premium on bond issuance | 4,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net settlements on interest rate swaps | -10,900,000 | -10,600,000 | -11,200,000 | -11,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents of facilities in discontinued operations at beginning of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents of facilities in discontinued operations at end of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
activities— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax refund receivable | 100,000 | -1,300,000 | -4,700,000 | 9,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
capital expenditures | -162,400,000 | -229,300,000 | -187,100,000 | -156,900,000 | -163,100,000 | -198,700,000 | -147,500,000 | -156,900,000 | -139,400,000 | 0 | -146,700,000 | -117,200,000 | -96,600,000 | -189,900,000 | -141,900,000 | -114,800,000 | -115,200,000 | -192,600,000 | -123,600,000 | -113,900,000 | -98,800,000 | -139,800,000 | -89,600,000 | -83,100,000 | -83,500,000 | -350,100,000 | -8,700,000 | 58,700,000 | -72,300,000 | -231,200,000 | -5,300,000 | 41,900,000 | -59,900,000 | -202,300,000 | -10,400,000 | -7,900,000 | -5,200,000 | -168,500,000 | -12,100,000 | 26,100,000 | -39,100,000 | 65,500,000 | -86,900,000 | -46,000,000 | -36,900,000 | -63,600,000 | -101,500,000 | -42,700,000 | -38,200,000 | -31,500,000 | -15,300,000 | -20,300,000 | -15,900,000 | -14,000,000 | -20,800,000 | -10,000,000 | -8,700,000 | 0 | -10,000,000 | -9,200,000 | -6,000,000 | -35,246,000 | -22,439,000 | -20,774,000 |
free cash flows | 150,700,000 | 116,700,000 | 83,700,000 | 113,300,000 | 125,500,000 | 80,100,000 | 120,300,000 | 60,500,000 | 99,400,000 | 201,000,000 | 68,500,000 | 89,500,000 | 131,300,000 | -17,700,000 | -71,800,000 | 129,800,000 | 103,700,000 | -68,800,000 | 54,000,000 | 142,000,000 | 59,700,000 | 139,900,000 | 83,800,000 | 139,200,000 | -54,200,000 | 328,900,000 | -14,200,000 | -139,400,000 | 87,600,000 | 547,600,000 | -7,900,000 | -188,200,000 | 156,400,000 | 407,900,000 | 4,000,000 | -20,400,000 | 39,900,000 | 359,200,000 | 34,200,000 | -102,100,000 | 120,600,000 | -273,100,000 | 295,300,000 | 93,600,000 | 91,100,000 | 43,500,000 | 41,100,000 | 62,700,000 | 83,200,000 | 77,800,000 | 73,800,000 | 76,500,000 | 72,000,000 | 70,800,000 | 61,500,000 | 15,200,000 | 33,100,000 | 376,300,000 | -44,600,000 | -114,400,000 | -11,800,000 | -60,317,000 | -1,690,000 | -92,087,000 |
distributions paid to noncontrolling interests of | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
consolidated affiliates | -13,300,000 | -8,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents of facilities held for sale | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
at beginning of period | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents of facilities held for | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale at end of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash provided by | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating activities— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ubs settlement proceeds, gross | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt issue costs, debt discounts, and fees | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred tax provision | 300,000 | 1,700,000 | 400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued fees and expenses for derivative plaintiffs' attorneys in | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ubs settlement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net investment in interest rate swap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities of discontinued | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operations | 0 | -200,000 | -1,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
securities litigation settlement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in net (income) loss of nonconsolidated affiliates | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of a business, net of cash acquired | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued fees and expenses for derivative plaintiffs' attorneys in ubs settlement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of restricted marketable securities | 3,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
checks in excess of bank balance | -5,900,000 | 5,900,000 | -11,400,000 | 13,300,000 | -28,800,000 | 26,100,000 | 21,559,000 | -27,752,000 | -2,223,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents of facilities held for sale at beginning of period | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents of facilities held for sale at end of period | -100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale and maturities of restricted marketable securities | 1,100,000 | 800,000 | 500,000 | 500,000 | 300,000 | 65,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in restricted cash, excluding cash in escrow related to debt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net settlements on interest rate swap | -7,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities of discontinued operations - | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from divestitures of divisions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
change in restricted cash for amounts in escrow related to debt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distributions to minority interests of consolidated affiliates | -9,800,000 | -6,400,000 | -10,100,000 | -7,500,000 | 11,100,000 | -23,100,000 | -23,438,000 | -19,055,000 | -21,537,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | 0 | -411,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents of divisions and facilities held for sale at | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
beginning of period | 0 | 0 | 400,000 | 14,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents of divisions and facilities held for sale | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
at end of period | -300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal payments on debt | -17,000,000 | -55,900,000 | -859,800,000 | -5,200,000 | -5,362,000 | -1,026,512,000 | -3,400,177,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equivalents | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale and maturities of marketable securities | -245,000 | 1,091,000 | 31,218,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from divestiture of divisions | 56,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of convertible perpetual preferred stock | 0 | 0 | 400,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock issuance costs | 0 | -49,000 | -12,548,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate on cash and cash equivalents | 0 | 0 | 100,000 | 439,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents of divisions and facilities held for sale at beginning | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
of period | 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents of divisions and facilities held for sale at end | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity interests of consolidated affiliates | 2,300,000 | 4,002,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of equity interests of consolidated affiliates | -1,600,000 | -4,160,000 | -2,437,000 | -2,637,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash settlement on interest rate swap | 600,000 | 367,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal borrowing on notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents of divisions and facilities held for sale at | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
end of period | -18,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of investments, net of cash equivalents | 51,722,000 | -59,264,000 | -8,144,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of restricted marketable securities, net of cash equivalents | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity interests of nonconsolidated affiliates | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of equity interests of nonconsolidated affiliates | -68,000 | 0 | -32,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances to nonconsolidated affiliates, net of cash received | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
return of investment of nonconsolidated affiiliates | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in cash related to conversion of consolidated affiliates to equity method affiliates | -904,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in cash related to conversion of equity method affiliates to consolidated affiliates | 0 | 0 | -103,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from repayment of notes receivable from shareholders, officers,and management employees | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents of discontinued operations at beginning of period | -13,000 | -116,000 | 2,093,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents of discontinued operations at end of period | 609,000 | 653,000 | -1,716,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from repayment of notes receivable from shareholders, officers, and management employees | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity interests on nonconsolidated affiliates | 1,529,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity interests on consolidated affiliates | 9,994,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of treasury stock | -46,000 |